| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 KRT80 KRT76 KRT6C KRT71 KRT77 | 6.60e-20 | 43 | 110 | 13 | GO:0030280 |
| GeneOntologyMolecularFunction | structural molecule activity | TPM1 ROCK2 KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B FRAS1 MYOM1 KRT84 SPTBN1 EVPL NEB PPL KRT80 NEFM MAGI2 KRT76 KRT6C KRT71 KRT77 H1-6 EIF3A DMD | 1.80e-12 | 891 | 110 | 26 | GO:0005198 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | TPM1 KRT2 KRT5 KRT6A KRT6B MYOM1 KRT84 SPTBN1 PPL NEFM KRT71 DMD | 7.09e-12 | 130 | 110 | 12 | GO:0005200 |
| GeneOntologyMolecularFunction | actin filament binding | TPM1 MYH1 MYH2 MYH3 MYH7 MYH9 MYH13 CAPG SPTBN1 VPS16 NEB SIPA1L1 TAGLN2 | 3.76e-10 | 227 | 110 | 13 | GO:0051015 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPM1 ROCK2 KRT2 MYH1 MYH2 MYH3 MYH7 MYH9 MYH13 CLIP2 CAPG SPTBN1 VPS16 NEB NEFM MAGI2 EFHC1 SNX6 SIPA1L1 FES TAGLN2 KIF5C DMD | 2.54e-08 | 1099 | 110 | 23 | GO:0008092 |
| GeneOntologyMolecularFunction | microfilament motor activity | 5.83e-08 | 38 | 110 | 6 | GO:0000146 | |
| GeneOntologyMolecularFunction | actin binding | TPM1 MYH1 MYH2 MYH3 MYH7 MYH9 MYH13 CAPG SPTBN1 VPS16 NEB SIPA1L1 TAGLN2 DMD | 3.88e-07 | 479 | 110 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | deaminase binding | 6.48e-07 | 4 | 110 | 3 | GO:1990827 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.05e-06 | 118 | 110 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | translation factor activity, RNA binding | 7.48e-06 | 85 | 110 | 6 | GO:0008135 | |
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | 1.87e-05 | 206 | 110 | 8 | GO:0043021 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 3.63e-05 | 112 | 110 | 6 | GO:0090079 | |
| GeneOntologyMolecularFunction | calmodulin binding | 4.10e-05 | 230 | 110 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 7.05e-05 | 15 | 110 | 3 | GO:1990247 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 9.12e-05 | 43 | 110 | 4 | GO:0008307 | |
| GeneOntologyMolecularFunction | translation initiation factor activity | 1.78e-04 | 51 | 110 | 4 | GO:0003743 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 3.03e-04 | 24 | 110 | 3 | GO:0140517 | |
| GeneOntologyMolecularFunction | telomerase RNA binding | 3.42e-04 | 25 | 110 | 3 | GO:0070034 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 5.77e-04 | 614 | 110 | 11 | GO:0140657 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 8.60e-04 | 34 | 110 | 3 | GO:0008266 | |
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | 1.29e-03 | 39 | 110 | 3 | GO:0008187 | |
| GeneOntologyMolecularFunction | cadherin binding | 2.73e-03 | 339 | 110 | 7 | GO:0045296 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 EVPL VPS54 PPL KRT80 NEFM KRT76 KRT6C KRT71 KRT77 | 1.75e-21 | 99 | 108 | 17 | GO:0045104 |
| GeneOntologyBiologicalProcess | intermediate filament-based process | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 EVPL VPS54 PPL KRT80 NEFM KRT76 KRT6C KRT71 KRT77 | 2.09e-21 | 100 | 108 | 17 | GO:0045103 |
| GeneOntologyBiologicalProcess | keratinization | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 EVPL PPL KRT80 KRT76 KRT6C KRT71 KRT77 | 4.29e-19 | 87 | 108 | 15 | GO:0031424 |
| GeneOntologyBiologicalProcess | intermediate filament organization | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 KRT80 NEFM KRT76 KRT6C KRT71 KRT77 | 2.10e-18 | 75 | 108 | 14 | GO:0045109 |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | ROCK2 KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 EVPL PPL KRT80 KRT76 KRT6C KRT71 KRT77 | 3.17e-15 | 189 | 108 | 16 | GO:0030216 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | TPM1 ROCK2 KRT1 KRT2 KRT3 KRT4 KRT5 MYH3 KRT6A KRT6B MYH7 MYH9 MYOM1 CLIP2 KRT84 CAPG SPTBN1 NEB KRT80 NEFM TTC8 FCHSD2 KRT76 KRT6C KRT71 KRT77 FES TAGLN2 OCLN | 7.04e-15 | 957 | 108 | 29 | GO:0097435 |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | ROCK2 KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 EVPL PPL KRT80 KRT76 KRT6C KRT71 KRT77 SPINK5 | 1.27e-13 | 284 | 108 | 17 | GO:0009913 |
| GeneOntologyBiologicalProcess | skin development | ROCK2 KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B FRAS1 KRT84 EVPL PPL KRT80 KRT76 KRT6C KRT71 KRT77 SPINK5 | 9.00e-13 | 373 | 108 | 18 | GO:0043588 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | ROCK2 KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 EVPL PPL KRT80 MAGI2 TTC8 SIDT2 KRT76 KRT6C KRT71 KRT77 NR5A1 TAGLN2 DMD SPINK5 | 1.08e-10 | 870 | 108 | 23 | GO:0030855 |
| GeneOntologyBiologicalProcess | epidermis development | ROCK2 KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 EVPL PPL KRT80 KRT76 KRT6C KRT71 KRT77 SPINK5 | 2.75e-10 | 461 | 108 | 17 | GO:0008544 |
| GeneOntologyBiologicalProcess | epithelium development | ROCK2 KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B FRAS1 KRT84 EVPL PPL KRT80 MAGI2 TTC8 SIDT2 KRT76 KRT6C KRT71 KRT77 NR5A1 TAGLN2 DMD SPINK5 | 4.59e-07 | 1469 | 108 | 24 | GO:0060429 |
| GeneOntologyBiologicalProcess | muscle filament sliding | 9.28e-07 | 15 | 108 | 4 | GO:0030049 | |
| GeneOntologyBiologicalProcess | muscle contraction | TPM1 ROCK2 MYH1 MYH2 MYH3 MYH7 MYH13 MYOM1 VPS54 CLIC2 DMD SCN3B | 1.25e-06 | 400 | 108 | 12 | GO:0006936 |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 2.06e-06 | 18 | 108 | 4 | GO:0033275 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA modification | 2.76e-06 | 6 | 108 | 3 | GO:0090367 | |
| GeneOntologyBiologicalProcess | regulation of mRNA modification | 4.81e-06 | 7 | 108 | 3 | GO:0090365 | |
| GeneOntologyBiologicalProcess | striated muscle cell development | 7.32e-06 | 89 | 108 | 6 | GO:0055002 | |
| GeneOntologyBiologicalProcess | regulation of antibacterial peptide production | 1.15e-05 | 9 | 108 | 3 | GO:0002786 | |
| GeneOntologyBiologicalProcess | sarcomere organization | 1.43e-05 | 59 | 108 | 5 | GO:0045214 | |
| GeneOntologyBiologicalProcess | regulation of antimicrobial peptide production | 2.23e-05 | 11 | 108 | 3 | GO:0002784 | |
| GeneOntologyBiologicalProcess | muscle system process | TPM1 ROCK2 MYH1 MYH2 MYH3 MYH7 MYH13 MYOM1 VPS54 CLIC2 DMD SCN3B | 2.96e-05 | 547 | 108 | 12 | GO:0003012 |
| GeneOntologyBiologicalProcess | antibacterial peptide production | 2.97e-05 | 12 | 108 | 3 | GO:0002778 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 3.76e-05 | 239 | 108 | 8 | GO:0031032 | |
| GeneOntologyBiologicalProcess | regulation of antimicrobial humoral response | 4.87e-05 | 14 | 108 | 3 | GO:0002759 | |
| GeneOntologyBiologicalProcess | antimicrobial peptide production | 4.87e-05 | 14 | 108 | 3 | GO:0002775 | |
| GeneOntologyBiologicalProcess | protein heterotetramerization | 7.44e-05 | 16 | 108 | 3 | GO:0051290 | |
| GeneOntologyBiologicalProcess | actin filament-based process | TPM1 ROCK2 MYH2 MYH3 MYH7 MYH9 MYOM1 CAPG SPTBN1 NEB TTC8 FCHSD2 SIPA1L1 TAGLN2 SCN3B | 8.08e-05 | 912 | 108 | 15 | GO:0030029 |
| GeneOntologyBiologicalProcess | myofibril assembly | 8.92e-05 | 86 | 108 | 5 | GO:0030239 | |
| GeneOntologyBiologicalProcess | actin filament capping | 9.79e-05 | 46 | 108 | 4 | GO:0051693 | |
| GeneOntologyBiologicalProcess | microtubule-based process | ROCK2 MYH9 CLIP2 CNTLN NEFM FSIP2 EFHC1 TMEM232 H1-6 FES KIF5C OCLN ZW10 PIBF1 ARHGAP21 CFAP46 | 1.22e-04 | 1058 | 108 | 16 | GO:0007017 |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.47e-04 | 217 | 108 | 7 | GO:0006941 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.55e-04 | 153 | 108 | 6 | GO:0030048 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 1.59e-04 | 52 | 108 | 4 | GO:0030835 | |
| GeneOntologyBiologicalProcess | intermediate filament polymerization or depolymerization | 1.62e-04 | 4 | 108 | 2 | GO:0045105 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 2.16e-04 | 231 | 108 | 7 | GO:0032271 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | TPM1 ROCK2 MYH3 MYH7 MYH9 MYOM1 CAPG SPTBN1 NEB TTC8 FCHSD2 SIPA1L1 TAGLN2 | 2.91e-04 | 803 | 108 | 13 | GO:0030036 |
| GeneOntologyBiologicalProcess | regulation of actin filament depolymerization | 2.95e-04 | 61 | 108 | 4 | GO:0030834 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance via telomerase | 2.95e-04 | 25 | 108 | 3 | GO:0032211 | |
| GeneOntologyBiologicalProcess | mRNA modification | 3.32e-04 | 26 | 108 | 3 | GO:0016556 | |
| GeneOntologyBiologicalProcess | regulation of actin filament length | 3.72e-04 | 180 | 108 | 6 | GO:0030832 | |
| GeneOntologyBiologicalProcess | peptide cross-linking | 3.73e-04 | 27 | 108 | 3 | GO:0018149 | |
| GeneOntologyBiologicalProcess | protein polymerization | 3.76e-04 | 334 | 108 | 8 | GO:0051258 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | ROCK2 MYH9 CLIP2 CNTLN NEFM FSIP2 EFHC1 FES OCLN ZW10 PIBF1 CFAP46 | 3.89e-04 | 720 | 108 | 12 | GO:0000226 |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 3.99e-04 | 66 | 108 | 4 | GO:0030042 | |
| GeneOntologyBiologicalProcess | musculoskeletal movement | 4.73e-04 | 69 | 108 | 4 | GO:0050881 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | 4.95e-04 | 438 | 108 | 9 | GO:1902903 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 5.49e-04 | 127 | 108 | 5 | GO:0070252 | |
| GeneOntologyBiologicalProcess | protein heterooligomerization | 5.64e-04 | 31 | 108 | 3 | GO:0051291 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 5.64e-04 | 31 | 108 | 3 | GO:0070935 | |
| GeneOntologyBiologicalProcess | multicellular organismal movement | 5.86e-04 | 73 | 108 | 4 | GO:0050879 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament polymerization | 6.49e-04 | 75 | 108 | 4 | GO:0030837 | |
| GeneOntologyBiologicalProcess | translational initiation | 6.55e-04 | 132 | 108 | 5 | GO:0006413 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance via telomere lengthening | 6.79e-04 | 33 | 108 | 3 | GO:1904357 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral immune response mediated by antimicrobial peptide | 7.01e-04 | 134 | 108 | 5 | GO:0061844 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | 9.26e-04 | 579 | 108 | 10 | GO:0051493 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | 9.36e-04 | 384 | 108 | 8 | GO:0032956 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 1.02e-03 | 300 | 108 | 7 | GO:0110053 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 1.13e-03 | 87 | 108 | 4 | GO:1902373 | |
| GeneOntologyBiologicalProcess | wound healing | 1.14e-03 | 493 | 108 | 9 | GO:0042060 | |
| GeneOntologyBiologicalProcess | limb development | 1.17e-03 | 224 | 108 | 6 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 1.17e-03 | 224 | 108 | 6 | GO:0048736 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 1.23e-03 | 89 | 108 | 4 | GO:1901880 | |
| GeneOntologyBiologicalProcess | negative regulation of protein polymerization | 1.34e-03 | 91 | 108 | 4 | GO:0032272 | |
| GeneOntologyBiologicalProcess | negative regulation of telomere maintenance | 1.38e-03 | 42 | 108 | 3 | GO:0032205 | |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 1.38e-03 | 156 | 108 | 5 | GO:0032989 | |
| GeneOntologyBiologicalProcess | regulation of actin filament polymerization | 1.38e-03 | 156 | 108 | 5 | GO:0030833 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 1.38e-03 | 156 | 108 | 5 | GO:0010927 | |
| GeneOntologyBiologicalProcess | actin filament organization | 1.43e-03 | 509 | 108 | 9 | GO:0007015 | |
| GeneOntologyBiologicalProcess | neurofilament cytoskeleton organization | 1.45e-03 | 11 | 108 | 2 | GO:0060052 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA biosynthetic process | 1.48e-03 | 43 | 108 | 3 | GO:2000279 | |
| GeneOntologyCellularComponent | supramolecular fiber | TPM1 KRT1 KRT2 KRT3 MYH1 KRT4 MYH2 KRT5 MYH3 KRT6A KRT6B MYH7 MYH9 MYH13 MYOM1 CLIP2 RIBC2 CEP162 KRT84 SPTBN1 EVPL VPS16 NEB PPL KRT80 NEFM EFHC1 KRT76 TMEM232 KRT6C KRT71 KRT77 BYSL EIF3A KIF5C DMD ZW10 SCN3B | 1.33e-20 | 1179 | 109 | 38 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TPM1 KRT1 KRT2 KRT3 MYH1 KRT4 MYH2 KRT5 MYH3 KRT6A KRT6B MYH7 MYH9 MYH13 MYOM1 CLIP2 RIBC2 CEP162 KRT84 SPTBN1 EVPL VPS16 NEB PPL KRT80 NEFM EFHC1 KRT76 TMEM232 KRT6C KRT71 KRT77 BYSL EIF3A KIF5C DMD ZW10 SCN3B | 1.68e-20 | 1187 | 109 | 38 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TPM1 KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B MYH9 CLIP2 RIBC2 CEP162 KRT84 EVPL VPS16 PPL KRT80 NEFM EFHC1 KRT76 TMEM232 KRT6C KRT71 KRT77 BYSL EIF3A KIF5C DMD ZW10 | 1.30e-15 | 899 | 109 | 29 | GO:0099513 |
| GeneOntologyCellularComponent | intermediate filament | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 EVPL PPL KRT80 NEFM KRT76 KRT6C KRT71 KRT77 DMD | 3.00e-15 | 227 | 109 | 17 | GO:0005882 |
| GeneOntologyCellularComponent | keratin filament | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 KRT80 KRT76 KRT6C KRT71 KRT77 | 3.27e-15 | 97 | 109 | 13 | GO:0045095 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 EVPL PPL KRT80 NEFM KRT76 KRT6C KRT71 KRT77 DMD | 3.43e-14 | 263 | 109 | 17 | GO:0045111 |
| GeneOntologyCellularComponent | myosin filament | 3.84e-11 | 25 | 109 | 7 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 6.00e-09 | 28 | 109 | 6 | GO:0016460 | |
| GeneOntologyCellularComponent | actin cytoskeleton | TPM1 MYH1 MYH2 MYH3 MYH7 MYH9 HNRNPCL1 MYH13 CAPG SPTBN1 VPS16 NEB HNRNPCL3 SIPA1L1 TAGLN2 ARHGAP21 HNRNPCL2 | 7.50e-09 | 576 | 109 | 17 | GO:0015629 |
| GeneOntologyCellularComponent | muscle myosin complex | 1.47e-08 | 16 | 109 | 5 | GO:0005859 | |
| GeneOntologyCellularComponent | cornified envelope | 7.13e-08 | 69 | 109 | 7 | GO:0001533 | |
| GeneOntologyCellularComponent | myofibril | 1.91e-07 | 273 | 109 | 11 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.49e-07 | 290 | 109 | 11 | GO:0043292 | |
| GeneOntologyCellularComponent | multi-eIF complex | 5.50e-07 | 4 | 109 | 3 | GO:0043614 | |
| GeneOntologyCellularComponent | myosin complex | 6.30e-07 | 59 | 109 | 6 | GO:0016459 | |
| GeneOntologyCellularComponent | sarcomere | 7.29e-07 | 249 | 109 | 10 | GO:0030017 | |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 2.73e-06 | 6 | 109 | 3 | GO:1990826 | |
| GeneOntologyCellularComponent | eukaryotic 48S preinitiation complex | 1.06e-04 | 18 | 109 | 3 | GO:0033290 | |
| GeneOntologyCellularComponent | eukaryotic 43S preinitiation complex | 1.26e-04 | 19 | 109 | 3 | GO:0016282 | |
| GeneOntologyCellularComponent | translation preinitiation complex | 1.47e-04 | 20 | 109 | 3 | GO:0070993 | |
| GeneOntologyCellularComponent | A band | 1.56e-04 | 52 | 109 | 4 | GO:0031672 | |
| GeneOntologyCellularComponent | telomerase holoenzyme complex | 2.92e-04 | 25 | 109 | 3 | GO:0005697 | |
| GeneOntologyCellularComponent | desmosome | 4.11e-04 | 28 | 109 | 3 | GO:0030057 | |
| GeneOntologyCellularComponent | pronucleus | 4.11e-04 | 28 | 109 | 3 | GO:0045120 | |
| GeneOntologyCellularComponent | actomyosin contractile ring | 5.56e-04 | 7 | 109 | 2 | GO:0005826 | |
| GeneOntologyCellularComponent | myofilament | 6.13e-04 | 32 | 109 | 3 | GO:0036379 | |
| GeneOntologyCellularComponent | cytoplasmic microtubule | 6.65e-04 | 133 | 109 | 5 | GO:0005881 | |
| GeneOntologyCellularComponent | BBSome | 7.39e-04 | 8 | 109 | 2 | GO:0034464 | |
| GeneOntologyCellularComponent | neurofilament | 2.35e-03 | 14 | 109 | 2 | GO:0005883 | |
| GeneOntologyCellularComponent | contractile ring | 2.35e-03 | 14 | 109 | 2 | GO:0070938 | |
| GeneOntologyCellularComponent | postsynaptic density | 2.51e-03 | 451 | 109 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | neuromuscular junction | 2.82e-03 | 112 | 109 | 4 | GO:0031594 | |
| GeneOntologyCellularComponent | asymmetric synapse | 3.53e-03 | 477 | 109 | 8 | GO:0032279 | |
| GeneOntologyCellularComponent | axonemal microtubule | 3.63e-03 | 59 | 109 | 3 | GO:0005879 | |
| GeneOntologyCellularComponent | sperm head-tail coupling apparatus | 3.90e-03 | 18 | 109 | 2 | GO:0120212 | |
| GeneOntologyCellularComponent | centriolar satellite | 4.55e-03 | 128 | 109 | 4 | GO:0034451 | |
| GeneOntologyCellularComponent | cell leading edge | 4.68e-03 | 500 | 109 | 8 | GO:0031252 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 4.85e-03 | 503 | 109 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | anchoring junction | MYH1 MYH2 MYH9 DSG3 EVPL PPL MAGI2 FCHSD2 FES DMD OCLN ARHGAP21 | 4.90e-03 | 976 | 109 | 12 | GO:0070161 |
| HumanPheno | Palmoplantar blistering | 1.83e-06 | 11 | 46 | 4 | HP:0007446 | |
| HumanPheno | Blistering by anatomical location | 2.74e-06 | 26 | 46 | 5 | HP:0033800 | |
| MousePheno | abnormal corneocyte morphology | 4.39e-06 | 18 | 89 | 4 | MP:0030605 | |
| MousePheno | abnormal epidermal layer morphology | 8.39e-06 | 271 | 89 | 10 | MP:0001216 | |
| MousePheno | blistering | 1.48e-05 | 24 | 89 | 4 | MP:0001208 | |
| MousePheno | abnormal tongue epithelium morphology | 2.41e-05 | 27 | 89 | 4 | MP:0000764 | |
| MousePheno | abnormal corneocyte envelope morphology | 3.97e-05 | 11 | 89 | 3 | MP:0009594 | |
| MousePheno | abnormal tongue morphology | 1.05e-04 | 118 | 89 | 6 | MP:0000762 | |
| MousePheno | abnormal skeletal muscle fiber type ratio | 1.18e-04 | 40 | 89 | 4 | MP:0009409 | |
| MousePheno | impaired skeletal muscle contractility | 1.72e-04 | 44 | 89 | 4 | MP:0002841 | |
| Domain | Keratin_II | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 KRT80 KRT76 KRT6C KRT71 KRT77 | 3.29e-23 | 26 | 107 | 13 | IPR003054 |
| Domain | Keratin_2_head | KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT84 KRT76 KRT6C KRT71 KRT77 | 3.02e-19 | 24 | 107 | 11 | IPR032444 |
| Domain | Keratin_2_head | KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT84 KRT76 KRT6C KRT71 KRT77 | 3.02e-19 | 24 | 107 | 11 | PF16208 |
| Domain | IF | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 KRT80 NEFM KRT76 KRT6C KRT71 KRT77 | 3.86e-18 | 72 | 107 | 14 | PS00226 |
| Domain | Filament | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 KRT80 NEFM KRT76 KRT6C KRT71 KRT77 | 4.76e-18 | 73 | 107 | 14 | PF00038 |
| Domain | IF | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 KRT80 NEFM KRT76 KRT6C KRT71 KRT77 | 8.72e-18 | 76 | 107 | 14 | IPR001664 |
| Domain | Intermediate_filament_CS | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 NEFM KRT76 KRT6C KRT71 KRT77 | 2.79e-17 | 63 | 107 | 13 | IPR018039 |
| Domain | Filament | KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT84 KRT80 NEFM KRT76 KRT6C KRT71 KRT77 | 1.49e-16 | 71 | 107 | 13 | SM01391 |
| Domain | Myosin_N | 1.47e-10 | 15 | 107 | 6 | PF02736 | |
| Domain | Myosin_N | 1.47e-10 | 15 | 107 | 6 | IPR004009 | |
| Domain | Myosin_tail_1 | 5.39e-10 | 18 | 107 | 6 | PF01576 | |
| Domain | Myosin_tail | 5.39e-10 | 18 | 107 | 6 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 7.84e-10 | 19 | 107 | 6 | IPR027401 | |
| Domain | - | 7.84e-10 | 19 | 107 | 6 | 4.10.270.10 | |
| Domain | Keratin_I | 5.35e-09 | 44 | 107 | 7 | IPR002957 | |
| Domain | Myosin_head_motor_dom | 7.30e-08 | 38 | 107 | 6 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 7.30e-08 | 38 | 107 | 6 | PS51456 | |
| Domain | Myosin_head | 7.30e-08 | 38 | 107 | 6 | PF00063 | |
| Domain | MYSc | 7.30e-08 | 38 | 107 | 6 | SM00242 | |
| Domain | GrpE_coiled_coil | 4.86e-07 | 12 | 107 | 4 | IPR013805 | |
| Domain | Spectrin_repeat | 5.98e-07 | 29 | 107 | 5 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 1.00e-06 | 32 | 107 | 5 | IPR018159 | |
| Domain | SPEC | 1.00e-06 | 32 | 107 | 5 | SM00150 | |
| Domain | hnRNP_C | 3.61e-06 | 6 | 107 | 3 | IPR017347 | |
| Domain | IQ | 7.03e-06 | 81 | 107 | 6 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.29e-05 | 90 | 107 | 6 | IPR000048 | |
| Domain | IQ | 1.56e-05 | 93 | 107 | 6 | PS50096 | |
| Domain | TIF_eIF-1A_CS | 3.25e-05 | 2 | 107 | 2 | IPR018104 | |
| Domain | IQ | 5.42e-05 | 71 | 107 | 5 | PF00612 | |
| Domain | SNX5/SNX6/SNX32 | 9.72e-05 | 3 | 107 | 2 | IPR014637 | |
| Domain | TIF_eIF-1A | 9.72e-05 | 3 | 107 | 2 | PD005579 | |
| Domain | IF1A | 9.72e-05 | 3 | 107 | 2 | PS01262 | |
| Domain | S1_IF1_TYPE | 1.94e-04 | 4 | 107 | 2 | PS50832 | |
| Domain | eIF1a | 1.94e-04 | 4 | 107 | 2 | SM00652 | |
| Domain | RNA-binding_domain_S1_IF1 | 1.94e-04 | 4 | 107 | 2 | IPR006196 | |
| Domain | eIF-1a | 1.94e-04 | 4 | 107 | 2 | PF01176 | |
| Domain | TIF_eIF-1A | 1.94e-04 | 4 | 107 | 2 | IPR001253 | |
| Domain | Vps5 | 3.22e-04 | 5 | 107 | 2 | PF09325 | |
| Domain | Vps5_C | 3.22e-04 | 5 | 107 | 2 | IPR015404 | |
| Domain | tRNA-bd_arm | 3.39e-04 | 24 | 107 | 3 | IPR010978 | |
| Domain | HR1_rho-bd | 3.84e-04 | 25 | 107 | 3 | IPR011072 | |
| Domain | Plectin_repeat | 6.70e-04 | 7 | 107 | 2 | IPR001101 | |
| Domain | Plectin | 6.70e-04 | 7 | 107 | 2 | PF00681 | |
| Domain | PLEC | 6.70e-04 | 7 | 107 | 2 | SM00250 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B DSG3 KRT84 EVPL PPL KRT80 KRT76 KRT6C KRT71 KRT77 SPINK5 | 3.99e-18 | 129 | 90 | 17 | M27649 |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B DSG3 KRT84 EVPL PPL KRT80 KRT76 KRT71 KRT77 SPINK5 | 6.42e-18 | 87 | 90 | 15 | MM15351 |
| Pathway | REACTOME_KERATINIZATION | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B DSG3 KRT84 EVPL PPL KRT80 KRT76 KRT6C KRT71 KRT77 SPINK5 | 2.83e-14 | 217 | 90 | 17 | M27640 |
| Pathway | REACTOME_KERATINIZATION | KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B DSG3 KRT84 EVPL PPL KRT80 KRT76 KRT71 KRT77 SPINK5 | 3.88e-14 | 153 | 90 | 15 | MM15343 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | ROCK2 KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B DSG3 KRT84 SPTBN1 EVPL GRIN1 PPL KRT80 KRT76 KRT71 KRT77 FES SPINK5 | 2.96e-10 | 502 | 90 | 19 | MM14537 |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 2.95e-07 | 70 | 90 | 7 | M12294 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | ROCK2 KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B MYH9 DSG3 KRT84 SPTBN1 EVPL GRIN1 TNRC6C PPL KRT80 KRT76 KRT6C KRT71 KRT77 FES NR5A1 OCLN SCN3B SPINK5 | 5.61e-07 | 1432 | 90 | 26 | M509 |
| Pathway | KEGG_TIGHT_JUNCTION | 1.94e-06 | 132 | 90 | 8 | M11355 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 4.03e-06 | 38 | 90 | 5 | M39549 | |
| Pathway | REACTOME_RHOBTB1_GTPASE_CYCLE | 1.77e-05 | 25 | 90 | 4 | MM15608 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 6.99e-05 | 35 | 90 | 4 | MM15005 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 7.83e-05 | 36 | 90 | 4 | M18647 | |
| Pathway | REACTOME_RHOBTB_GTPASE_CYCLE | 8.73e-05 | 37 | 90 | 4 | MM15683 | |
| Pathway | REACTOME_RHOBTB2_GTPASE_CYCLE | 5.23e-04 | 25 | 90 | 3 | MM15606 | |
| Pubmed | TPM1 ROCK2 KRT1 KRT2 FAM184B KRT3 MYH1 MYH2 KRT5 MYH3 KRT6A KRT6B MYH7 MYH9 HNRNPCL1 MYH13 KRT84 SPTBN1 DDX42 HMOX2 NEB PPL HNRNPCL3 NEFM KRT76 KRT6C KRT71 KRT77 H1-6 EIF3A KIF5C DMD ARHGAP21 HNRNPCL2 CFAP46 | 8.48e-22 | 1442 | 110 | 35 | 35575683 | |
| Pubmed | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 KRT80 KRT76 KRT6C KRT71 KRT77 | 1.40e-20 | 63 | 110 | 13 | 16831889 | |
| Pubmed | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT76 KRT6C KRT71 KRT77 | 3.10e-17 | 57 | 110 | 11 | 31862882 | |
| Pubmed | Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. | 9.73e-17 | 16 | 110 | 8 | 12399393 | |
| Pubmed | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B MYH9 HNRNPCL1 KRT84 FARSB KRT80 EIF1AY KRT76 KRT6C KRT71 EIF1AX GLYR1 KRT77 BYSL H1-6 EIF3A TAGLN2 KIF5C ZW10 HSPA4 | 2.15e-15 | 1153 | 110 | 26 | 29845934 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B MYH9 ABCF1 KRT84 SPTBN1 DDX42 KRT80 ZFHX4 KRT6C GLYR1 KRT77 BYSL EIF3A | 6.22e-14 | 605 | 110 | 19 | 28977666 |
| Pubmed | 7.27e-14 | 9 | 110 | 6 | 15737194 | ||
| Pubmed | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B MYH9 IMPDH2 KRT84 SPTBN1 KRT76 KRT6C KRT77 | 1.59e-13 | 266 | 110 | 14 | 19380743 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | ROCK2 KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B MYH9 MYH13 IMPDH2 KRT84 SPTBN1 KRT80 KRT71 MTMR14 KRT77 EIF3A HSPA4 | 1.93e-13 | 558 | 110 | 18 | 27591049 |
| Pubmed | TPM1 ROCK2 KRT1 KRT2 KRT5 KRT6A KRT6B MYH9 ABCF1 HNRNPCL1 CLIP2 SPTBN1 FARSB GRIN1 HNRNPCL3 NEFM MAGI2 KRT76 KIDINS220 SIPA1L1 EIF3A KIF5C DMD HSPA4 ARHGAP21 HNRNPCL2 | 3.20e-13 | 1431 | 110 | 26 | 37142655 | |
| Pubmed | TPM1 KRT1 KRT2 KRT5 KRT6A KRT6B MYH9 KRT84 SPTBN1 PPL KRT80 KRT6C KRT77 STEEP1 DMD GCN1 | 3.69e-12 | 488 | 110 | 16 | 31324722 | |
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | TPM1 KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B ABCF1 SPTBN1 KRT80 KRT77 HSPA4 | 5.57e-12 | 218 | 110 | 12 | 35831895 |
| Pubmed | 6.03e-12 | 7 | 110 | 5 | 35210422 | ||
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 6.85e-12 | 84 | 110 | 9 | 29563501 | |
| Pubmed | KRT1 KRT2 KRT5 KRT6B MYH9 IMPDH2 SPTBN1 FARSB LARP4 KRT80 EIF1AY KRT6C EIF3A TAGLN2 KIF5C GCN1 HSPA4 | 2.09e-11 | 641 | 110 | 17 | 36057605 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | TPM1 KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B MYH9 CAND2 SPTBN1 NEFM KRT76 KRT6C KRT77 GCN1 HSPA4 | 3.18e-11 | 564 | 110 | 16 | 21565611 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B MYH9 ABCF1 IMPDH2 DSG3 KRT84 SPTBN1 FARSB EVPL PPL KRT80 GLYR1 KRT77 SIPA1L1 BYSL EIF3A | 5.78e-11 | 1257 | 110 | 22 | 36526897 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ROCK2 KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B MYH9 ABCF1 IMPDH2 SPTBN1 FARSB LARP4 KRT6C EIF1AX MORF4L1 BYSL PGLS EIF3A TAGLN2 GCN1 HSPA4 SPINK5 | 8.53e-11 | 1415 | 110 | 23 | 28515276 |
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 1.03e-10 | 113 | 110 | 9 | 34474245 | |
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | KRT1 MTIF3 KRT2 KRT3 KRT4 KRT5 KRT6B HMOX2 KRT80 KRT76 KRT6C KRT71 KRT77 MORF4L1 NKAPL SCN3B | 1.61e-10 | 630 | 110 | 16 | 36949045 |
| Pubmed | 4.09e-10 | 54 | 110 | 7 | 35474131 | ||
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 5.29e-10 | 91 | 110 | 8 | 34445801 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPM1 KRT1 KRT2 KRT5 MYH7 MYH9 ABCF1 CAND2 IMPDH2 SPTBN1 DDX42 FARSB NEFM KRT71 SNX6 EIF3A TAGLN2 ZW10 GCN1 HSPA4 | 5.34e-10 | 1149 | 110 | 20 | 35446349 |
| Pubmed | TPM1 KRT1 KRT2 KRT5 KRT6A KRT6B MYH9 IMPDH2 CEP162 FARSB KRT6C KRT77 EIF3A TAGLN2 KIF5C GCN1 HSPA4 | 6.64e-10 | 803 | 110 | 17 | 36517590 | |
| Pubmed | 7.76e-10 | 197 | 110 | 10 | 23686814 | ||
| Pubmed | 1.41e-09 | 6 | 110 | 4 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 1.41e-09 | 6 | 110 | 4 | 10077619 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 1.41e-09 | 6 | 110 | 4 | 10588881 | |
| Pubmed | 1.94e-09 | 107 | 110 | 8 | 32989256 | ||
| Pubmed | MYH9 ABCF1 IMPDH2 SPTBN1 DDX42 FARSB LARP4 NEFM MTMR14 GLYR1 KRT77 BYSL EIF3A HSPA4 | 2.43e-09 | 551 | 110 | 14 | 34728620 | |
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 3.29e-09 | 7 | 110 | 4 | 29758057 | |
| Pubmed | 3.29e-09 | 7 | 110 | 4 | 16819597 | ||
| Pubmed | 3.89e-09 | 305 | 110 | 11 | 33194618 | ||
| Pubmed | KRT1 KRT5 MYH9 SPTBN1 FARSB KRT80 KRT6C KRT77 EIF3A TAGLN2 GCN1 | 4.92e-09 | 312 | 110 | 11 | 37120454 | |
| Pubmed | KRT1 KRT2 KRT5 MYH9 ABCF1 IMPDH2 SPTBN1 FARSB KIDINS220 CLIC2 BYSL EIF3A TAGLN2 ZW10 GCN1 | 7.13e-09 | 707 | 110 | 15 | 19738201 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KRT1 MTIF3 KRT2 KRT5 KRT6A MYH9 ABCF1 HNRNPCL1 IMPDH2 SPTBN1 DDX42 NEFM KIDINS220 EIF1AX GLYR1 MORF4L1 NKAPL GCN1 | 8.71e-09 | 1082 | 110 | 18 | 38697112 |
| Pubmed | KRT2 MYH1 MYH2 KRT5 KRT6B MYH9 ABCF1 HNRNPCL1 IMPDH2 FARSB NEB NEFM H1-6 TAGLN2 DMD GCN1 | 1.05e-08 | 844 | 110 | 16 | 25963833 | |
| Pubmed | 1.17e-08 | 24 | 110 | 5 | 30719818 | ||
| Pubmed | 1.17e-08 | 24 | 110 | 5 | 27507811 | ||
| Pubmed | 1.76e-08 | 202 | 110 | 9 | 24639526 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TPM1 MYH1 MYH2 MYH3 MYH7 MYH9 MYH13 IMPDH2 SPTBN1 KRT80 EIF3A TAGLN2 ZW10 HSPA4 | 1.84e-08 | 647 | 110 | 14 | 26618866 |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | TPM1 KRT6A KRT6B MYH9 HNRNPCL1 IMPDH2 SPTBN1 KRT76 EIF3A HSPA4 | 2.93e-08 | 288 | 110 | 10 | 31501420 |
| Pubmed | 3.07e-08 | 11 | 110 | 4 | 18310078 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 3.07e-08 | 11 | 110 | 4 | 16024798 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 29357356 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 29587848 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 14573483 | ||
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 21470888 | ||
| Pubmed | Structural and developmental analysis of two linked myosin heavy chain genes. | 3.08e-08 | 3 | 110 | 3 | 1371481 | |
| Pubmed | 3.08e-08 | 3 | 110 | 3 | 7543104 | ||
| Pubmed | Identification of a cloned sequence activated during multi-stage carcinogenesis in mouse skin. | 3.08e-08 | 3 | 110 | 3 | 1713533 | |
| Pubmed | Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting. | 3.62e-08 | 155 | 110 | 8 | 22673621 | |
| Pubmed | 3.80e-08 | 60 | 110 | 6 | 31220272 | ||
| Pubmed | 4.60e-08 | 12 | 110 | 4 | 8424456 | ||
| Pubmed | KRT5 MYH9 CLIP2 SPTBN1 EVPL NEB ZNF106 EIF3A DMD PIBF1 RGL2 GCN1 | 4.94e-08 | 486 | 110 | 12 | 20936779 | |
| Pubmed | TPM1 MYH3 MYH7 CAND2 MYOM1 SPTBN1 NEB MTMR14 SNX6 MORF4L1 EIF3A ARHGAP21 | 6.30e-08 | 497 | 110 | 12 | 23414517 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 6.63e-08 | 13 | 110 | 4 | 8404542 | |
| Pubmed | 6.63e-08 | 13 | 110 | 4 | 8999895 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | KRT5 DSG3 CAPG EVPL CNTLN ITIH4 PPL KIDINS220 SIPA1L1 PGLS TAGLN2 GCN1 ARHGAP21 SPINK5 | 8.45e-08 | 732 | 110 | 14 | 34732716 |
| Pubmed | 9.25e-08 | 14 | 110 | 4 | 27184118 | ||
| Pubmed | 1.02e-07 | 329 | 110 | 10 | 35562734 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 20357587 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 23831410 | ||
| Pubmed | hnRNPC induces isoform shifts in miR-21-5p leading to cancer development. | 1.23e-07 | 4 | 110 | 3 | 35729324 | |
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 36681355 | ||
| Pubmed | Nonmuscle myosins IIA and IIB are present in adult motor nerve terminals. | 1.23e-07 | 4 | 110 | 3 | 16012337 | |
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 10388558 | ||
| Pubmed | hnRNP C is required for postimplantation mouse development but Is dispensable for cell viability. | 1.23e-07 | 4 | 110 | 3 | 10805751 | |
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 1.26e-07 | 15 | 110 | 4 | 24852826 | |
| Pubmed | 1.47e-07 | 75 | 110 | 6 | 31527668 | ||
| Pubmed | TPM1 MYH1 MYH7 MYH9 IMPDH2 SPTBN1 KRT71 STEEP1 BYSL EIF3A DMD HSPA4 | 1.48e-07 | 538 | 110 | 12 | 28524877 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | MYH9 HNRNPCL1 IMPDH2 SPTBN1 HNRNPCL3 KRT76 EIF3A GCN1 HSPA4 HNRNPCL2 | 1.54e-07 | 344 | 110 | 10 | 30333137 |
| Pubmed | 1.62e-07 | 346 | 110 | 10 | 25324306 | ||
| Pubmed | 1.81e-07 | 191 | 110 | 8 | 33762435 | ||
| Pubmed | Myomesin 3, a novel structural component of the M-band in striated muscle. | 3.06e-07 | 5 | 110 | 3 | 18177667 | |
| Pubmed | Role for keratins 6 and 17 during wound closure in embryonic mouse skin. | 3.06e-07 | 5 | 110 | 3 | 12557214 | |
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 29846695 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 23075894 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 3.06e-07 | 5 | 110 | 3 | 3829126 | |
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 6879174 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 9128719 | ||
| Pubmed | Evaluating the role of hnRNP-C and FMRP in the cAMP-induced APP metabolism. | 3.06e-07 | 5 | 110 | 3 | 25809670 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 3.06e-07 | 5 | 110 | 3 | 12919077 | |
| Pubmed | Airway hillocks are injury-resistant reservoirs of unique plastic stem cells. | 3.06e-07 | 5 | 110 | 3 | 38693267 | |
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 6196357 | ||
| Pubmed | 3.06e-07 | 5 | 110 | 3 | 20301457 | ||
| Pubmed | Three epidermal and one simple epithelial type II keratin genes map to human chromosome 12. | 3.06e-07 | 5 | 110 | 3 | 1713141 | |
| Pubmed | Sox6 is required for normal fiber type differentiation of fetal skeletal muscle in mice. | 3.06e-07 | 5 | 110 | 3 | 17584907 | |
| Pubmed | Activated Braf induces esophageal dilation and gastric epithelial hyperplasia in mice. | 3.19e-07 | 45 | 110 | 5 | 28973166 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | TPM1 KRT1 KRT2 KRT5 KRT6A KRT6B MYH9 IMPDH2 SPTBN1 KRT77 EIF3A HSPA4 | 3.30e-07 | 580 | 110 | 12 | 35676659 |
| Pubmed | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis. | 3.48e-07 | 141 | 110 | 7 | 32322062 | |
| Pubmed | Mice deficient in involucrin, envoplakin, and periplakin have a defective epidermal barrier. | 3.54e-07 | 19 | 110 | 4 | 18166659 | |
| Pubmed | Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. | 3.54e-07 | 19 | 110 | 4 | 17002498 | |
| Pubmed | 3.57e-07 | 46 | 110 | 5 | 36147463 | ||
| Pubmed | HOXA5 plays tissue-specific roles in the developing respiratory system. | 3.57e-07 | 46 | 110 | 5 | 28827394 | |
| Pubmed | Proteomic and biochemical analysis of 14-3-3-binding proteins during C2-ceramide-induced apoptosis. | 3.83e-07 | 88 | 110 | 6 | 20618440 | |
| Pubmed | ROCK2 MYH9 IMPDH2 CLIP2 SPTBN1 FARSB GRIN1 ITIH4 NEFM MAGI2 SIPA1L1 MORF4L1 KIF5C QSER1 ARHGAP21 | 3.93e-07 | 963 | 110 | 15 | 28671696 | |
| Pubmed | AP-2 factors act in concert with Notch to orchestrate terminal differentiation in skin epidermis. | 5.44e-07 | 21 | 110 | 4 | 18824566 | |
| Pubmed | Bcl11b/Ctip2 is required for development of lingual papillae in mice. | 5.44e-07 | 21 | 110 | 4 | 27287879 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | ROCK2 MYH2 MYH7 MYH9 IMPDH2 CEP162 MAGI2 KRT77 MORF4L1 STEEP1 FES RARS2 EIF3A TAGLN2 KIF5C ZW10 GCN1 | 5.98e-07 | 1284 | 110 | 17 | 17353931 |
| Interaction | KRT25 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B PPL KRT80 KRT76 KRT6C KRT71 KRT77 | 2.45e-21 | 35 | 110 | 13 | int:KRT25 |
| Interaction | KRT28 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT80 KRT76 KRT6C KRT71 | 3.84e-18 | 30 | 110 | 11 | int:KRT28 |
| Interaction | KRT8 interactions | KRT1 KRT2 KRT3 MYH1 KRT5 KRT6A KRT6B MYH9 CEP162 KRT84 TNRC6C PPL NEFM KRT76 KRT6C KRT71 KRT77 SIPA1L1 BYSL DMD PIBF1 ARHGAP21 | 2.34e-15 | 441 | 110 | 22 | int:KRT8 |
| Interaction | KRT36 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT80 KRT76 KRT6C KRT71 KRT77 | 6.25e-15 | 74 | 110 | 12 | int:KRT36 |
| Interaction | KRT15 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B RIBC2 KRT84 KRT80 EFHC1 KRT76 KRT6C KRT71 KRT77 | 4.85e-14 | 178 | 110 | 15 | int:KRT15 |
| Interaction | PHTF1 interactions | 7.26e-14 | 20 | 110 | 8 | int:PHTF1 | |
| Interaction | KRT84 interactions | 1.06e-13 | 49 | 110 | 10 | int:KRT84 | |
| Interaction | KRT19 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B CEP162 KRT84 KRT80 NEFM KRT76 KRT6C KRT71 KRT77 DMD PIBF1 | 2.24e-13 | 282 | 110 | 17 | int:KRT19 |
| Interaction | RNF208 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT76 KRT6C KRT71 KRT77 | 2.81e-13 | 75 | 110 | 11 | int:RNF208 |
| Interaction | KRT7 interactions | KRT1 KRT2 KRT5 KRT6A KRT6B KRT84 NEFM KRT76 KRT6C KRT77 EIF3A | 5.88e-13 | 80 | 110 | 11 | int:KRT7 |
| Interaction | KRT35 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT80 KRT76 KRT6C KRT71 KRT77 | 9.51e-13 | 111 | 110 | 12 | int:KRT35 |
| Interaction | KRT14 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 EVPL KRT80 NEFM KRT76 KRT6C KRT77 | 2.60e-12 | 192 | 110 | 14 | int:KRT14 |
| Interaction | KRT33B interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6B KRT80 KRT76 KRT6C KRT71 KRT77 | 3.22e-12 | 93 | 110 | 11 | int:KRT33B |
| Interaction | DES interactions | KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT84 NEB PPL NEFM KRT76 KRT6C KRT77 | 3.53e-12 | 158 | 110 | 13 | int:DES |
| Interaction | KRT16 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 KRT80 NEFM KRT76 KRT6C KRT71 KRT77 | 3.69e-12 | 197 | 110 | 14 | int:KRT16 |
| Interaction | PRPH interactions | ROCK2 KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT84 KRT76 KRT6C KRT71 SNX6 KRT77 ARHGAP21 | 5.93e-12 | 204 | 110 | 14 | int:PRPH |
| Interaction | KRT37 interactions | 7.26e-12 | 100 | 110 | 11 | int:KRT37 | |
| Interaction | KRT38 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT80 NEFM KRT76 KRT6C KRT71 PIBF1 | 1.04e-11 | 172 | 110 | 13 | int:KRT38 |
| Interaction | KRT26 interactions | 1.27e-11 | 35 | 110 | 8 | int:KRT26 | |
| Interaction | KRT18 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B CEP162 KRT84 NEFM EFHC1 KRT76 KRT6C KRT71 KRT77 PIBF1 HSPA4 CFAP46 | 1.27e-11 | 419 | 110 | 18 | int:KRT18 |
| Interaction | KRT24 interactions | 1.34e-11 | 54 | 110 | 9 | int:KRT24 | |
| Interaction | HEXIM1 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B MYH9 HNRNPCL1 KRT84 DDX42 FARSB KRT80 EIF1AY KRT76 KRT6C KRT71 EIF1AX KRT77 BYSL H1-6 EIF3A TAGLN2 KIF5C HSPA4 | 1.69e-11 | 913 | 110 | 25 | int:HEXIM1 |
| Interaction | KRT13 interactions | 3.75e-11 | 116 | 110 | 11 | int:KRT13 | |
| Interaction | KRT12 interactions | 3.81e-11 | 24 | 110 | 7 | int:KRT12 | |
| Interaction | KRT20 interactions | 5.71e-11 | 63 | 110 | 9 | int:KRT20 | |
| Interaction | LATS1 interactions | MYH1 KRT4 MYH2 KRT5 MYH3 KRT6A MYH7 MYH13 MYOM1 SPTBN1 TNRC6C NEB KRT6C MTMR14 GLYR1 SIPA1L1 HNRNPCL2 | 2.57e-10 | 440 | 110 | 17 | int:LATS1 |
| Interaction | KRT75 interactions | KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT84 EFHC1 KRT76 KRT6C KRT71 KRT77 | 3.13e-10 | 181 | 110 | 12 | int:KRT75 |
| Interaction | KRT5 interactions | KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B KRT84 EVPL KRT76 KRT6C KRT71 KRT77 | 6.55e-10 | 193 | 110 | 12 | int:KRT5 |
| Interaction | CFTR interactions | TPM1 KRT1 KRT2 MYH1 MYH2 KRT5 MYH3 KRT6A KRT6B MYH7 MYH9 MYH13 IMPDH2 KRT84 SPTBN1 PPL KRT80 OTC KRT6C MTMR14 KRT77 STEEP1 EIF3A TAGLN2 KIF5C DMD ZW10 GCN1 HSPA4 | 9.02e-10 | 1480 | 110 | 29 | int:CFTR |
| Interaction | KRT27 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B NEFM KRT76 KRT6C KRT71 KRT77 | 1.10e-09 | 202 | 110 | 12 | int:KRT27 |
| Interaction | KRT6A interactions | KRT2 KRT3 KRT5 KRT6A KRT6B DSG3 KRT84 KRT76 KRT6C KRT71 KRT77 | 1.21e-09 | 160 | 110 | 11 | int:KRT6A |
| Interaction | KRT40 interactions | KRT1 KRT2 KRT3 MYH1 KRT4 MYH2 KRT5 MYH3 KRT6A KRT6B MYH7 KRT76 KRT6C KRT71 BYSL PGLS | 1.78e-09 | 434 | 110 | 16 | int:KRT40 |
| Interaction | ZUP1 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B VPS54 VPS16 KRT80 KRT77 | 2.95e-09 | 174 | 110 | 11 | int:ZUP1 |
| Interaction | KRT31 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B MYOM1 KRT80 NEFM KRT76 KRT6C KRT71 KRT77 BYSL PGLS | 3.29e-09 | 453 | 110 | 16 | int:KRT31 |
| Interaction | KRT32 interactions | 3.86e-09 | 44 | 110 | 7 | int:KRT32 | |
| Interaction | EFNA1 interactions | 5.05e-09 | 103 | 110 | 9 | int:EFNA1 | |
| Interaction | CYLD interactions | ROCK2 KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B MYH9 MYH13 IMPDH2 KRT84 SPTBN1 TNRC6C KRT80 KRT71 MTMR14 KRT77 EIF3A PIBF1 GCN1 HSPA4 | 8.14e-09 | 868 | 110 | 21 | int:CYLD |
| Interaction | IQCB1 interactions | KRT1 KRT2 KRT5 KRT6A KRT6B MYH9 CAND2 CEP162 SPTBN1 NEFM KRT6C KRT77 GCN1 HSPA4 | 1.44e-08 | 370 | 110 | 14 | int:IQCB1 |
| Interaction | CHD3 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B MYH9 KRT84 SPTBN1 DDX42 KRT80 ZFHX4 KRT6C GLYR1 KRT77 BYSL EIF3A HNRNPCL2 | 2.59e-08 | 757 | 110 | 19 | int:CHD3 |
| Interaction | KRT39 interactions | 3.21e-08 | 59 | 110 | 7 | int:KRT39 | |
| Interaction | TSPAN33 interactions | 6.38e-08 | 65 | 110 | 7 | int:TSPAN33 | |
| Interaction | RNF8 interactions | TPM1 KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B ABCF1 SPTBN1 KRT80 KRT77 STEEP1 HSPA4 SCN3B | 7.21e-08 | 421 | 110 | 14 | int:RNF8 |
| Interaction | UBASH3B interactions | 1.99e-07 | 157 | 110 | 9 | int:UBASH3B | |
| Interaction | KRT34 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT80 KIDINS220 KRT6C KRT71 KRT77 | 4.30e-07 | 283 | 110 | 11 | int:KRT34 |
| Interaction | SHC1 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A MYH9 SPTBN1 HMOX2 MTMR14 KRT77 HSPA4 | 6.82e-07 | 362 | 110 | 12 | int:SHC1 |
| Interaction | EFNA4 interactions | 7.58e-07 | 239 | 110 | 10 | int:EFNA4 | |
| Interaction | THRB interactions | 8.34e-07 | 186 | 110 | 9 | int:THRB | |
| Interaction | KRT10 interactions | 8.72e-07 | 187 | 110 | 9 | int:KRT10 | |
| Interaction | MEPCE interactions | KRT1 KRT2 KRT5 KRT6A KRT6B HNRNPCL1 DDX42 KRT80 EIF1AY KRT76 KRT6C EIF1AX GLYR1 KRT77 BYSL H1-6 EIF3A HSPA4 | 8.95e-07 | 859 | 110 | 18 | int:MEPCE |
| Interaction | RSPH6A interactions | 1.08e-06 | 34 | 110 | 5 | int:RSPH6A | |
| Interaction | WTAP interactions | 1.18e-06 | 194 | 110 | 9 | int:WTAP | |
| Interaction | KIFC3 interactions | 1.23e-06 | 252 | 110 | 10 | int:KIFC3 | |
| Interaction | VIM interactions | ROCK2 KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B MYH9 RIBC2 KRT84 NEB PPL NEFM KRT76 KRT6C KRT77 BYSL | 1.65e-06 | 804 | 110 | 17 | int:VIM |
| Interaction | TRIM37 interactions | TPM1 KRT1 KRT2 MYH2 KRT5 KRT6A KRT6B MYH7 MYH9 MYH13 RIBC2 SPTBN1 SIPA1L1 BYSL PIBF1 | 1.70e-06 | 630 | 110 | 15 | int:TRIM37 |
| Interaction | PRKAG2 interactions | 1.92e-06 | 68 | 110 | 6 | int:PRKAG2 | |
| Interaction | EFNA3 interactions | 2.11e-06 | 108 | 110 | 7 | int:EFNA3 | |
| Interaction | DDX39B interactions | KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B MYH9 IMPDH2 KRT84 SPTBN1 KRT80 KRT6C KRT77 NR5A1 | 2.71e-06 | 570 | 110 | 14 | int:DDX39B |
| Interaction | CHD4 interactions | KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B MYH9 ABCF1 KRT84 DDX42 KRT80 ZFHX4 KRT6C GLYR1 KRT77 BYSL EIF3A HNRNPCL2 | 3.11e-06 | 938 | 110 | 18 | int:CHD4 |
| Interaction | ASAH2 interactions | 3.13e-06 | 6 | 110 | 3 | int:ASAH2 | |
| Interaction | CBL interactions | KRT1 KRT2 KRT3 MYH2 KRT5 KRT6A KRT6B MYH9 KRT84 SPTBN1 PPL KRT6C HSPA4 | 4.82e-06 | 516 | 110 | 13 | int:CBL |
| Interaction | STK3 interactions | 6.81e-06 | 181 | 110 | 8 | int:STK3 | |
| Interaction | COPS5 interactions | KRT1 KRT2 KRT3 KRT5 KRT6A KRT6B MYH9 ABCF1 HNRNPCL1 CAND2 IMPDH2 SPTBN1 DDX42 KRT80 KRT76 KRT6C KRT71 BYSL HSPA4 | 7.54e-06 | 1102 | 110 | 19 | int:COPS5 |
| Interaction | NDC80 interactions | 8.19e-06 | 312 | 110 | 10 | int:NDC80 | |
| Interaction | TNIP1 interactions | TPM1 KRT1 MYH9 ABCF1 HNRNPCL1 SPTBN1 TNRC6C LARP4 HNRNPCL3 EIF1AY NEFM GLYR1 MORF4L1 STEEP1 BYSL HNRNPCL4 EIF3A DMD PIBF1 HNRNPCL2 | 8.54e-06 | 1217 | 110 | 20 | int:TNIP1 |
| Interaction | LARP7 interactions | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B MYH9 HNRNPCL1 EIF1AY KRT76 KRT6C EIF1AX KRT77 BYSL H1-6 EIF3A ZW10 HSPA4 | 8.68e-06 | 1113 | 110 | 19 | int:LARP7 |
| Interaction | KRT17 interactions | 1.00e-05 | 252 | 110 | 9 | int:KRT17 | |
| Interaction | METTL14 interactions | KRT1 KRT2 KRT4 KRT5 KRT6B MYH9 ABCF1 SPTBN1 KRT80 KRT77 KIF5C GCN1 HSPA4 | 1.11e-05 | 558 | 110 | 13 | int:METTL14 |
| Interaction | ITSN1 interactions | 1.25e-05 | 259 | 110 | 9 | int:ITSN1 | |
| Interaction | AAR2 interactions | KRT1 KRT2 KRT5 KRT6A KRT6B MYH7 MYH9 ABCF1 FARSB PGLS EIF3A TAGLN2 GCN1 HSPA4 | 1.37e-05 | 657 | 110 | 14 | int:AAR2 |
| Interaction | LGR4 interactions | 1.37e-05 | 262 | 110 | 9 | int:LGR4 | |
| Interaction | KRT77 interactions | 1.43e-05 | 96 | 110 | 6 | int:KRT77 | |
| Interaction | TEX11 interactions | 1.52e-05 | 97 | 110 | 6 | int:TEX11 | |
| Interaction | RICTOR interactions | KRT1 KRT5 MYH9 ABCF1 SPTBN1 FARSB KRT80 KRT6C KRT77 EIF3A TAGLN2 OCLN NKAPL GCN1 HSPA4 | 1.60e-05 | 759 | 110 | 15 | int:RICTOR |
| Interaction | INVS interactions | 1.71e-05 | 99 | 110 | 6 | int:INVS | |
| Interaction | DCTN1 interactions | KRT2 KRT3 KRT5 KRT6A KRT6B CEP162 KRT84 SPTBN1 KRT76 KRT6C SNX6 ARHGAP21 | 1.75e-05 | 497 | 110 | 12 | int:DCTN1 |
| Interaction | FGD5 interactions | 1.81e-05 | 207 | 110 | 8 | int:FGD5 | |
| Interaction | KCTD13 interactions | TPM1 ROCK2 KRT1 KRT2 KRT5 KRT6A MYH9 ABCF1 CLIP2 SPTBN1 FARSB GRIN1 NEFM MAGI2 KIDINS220 SIPA1L1 EIF3A KIF5C DMD HSPA4 ARHGAP21 | 1.84e-05 | 1394 | 110 | 21 | int:KCTD13 |
| Interaction | ABTB2 interactions | 1.92e-05 | 101 | 110 | 6 | int:ABTB2 | |
| Interaction | SOX2 interactions | KRT5 IMPDH2 DSG3 CAPG SPTBN1 EVPL CNTLN ITIH4 PPL BRD8 KIDINS220 ZFHX4 GLYR1 SIPA1L1 PGLS NR5A1 TAGLN2 QSER1 GCN1 ARHGAP21 SPINK5 | 2.48e-05 | 1422 | 110 | 21 | int:SOX2 |
| Interaction | PCM1 interactions | KRT1 KRT2 FAM184B CEP162 CNTLN LARP4 UBR7 TTC8 MORF4L1 SECISBP2 PIBF1 | 2.56e-05 | 434 | 110 | 11 | int:PCM1 |
| Interaction | BAP1 interactions | TPM1 KRT1 KRT2 KRT5 MYH7 MYH9 ABCF1 CAND2 IMPDH2 SPTBN1 DDX42 FARSB NEFM KRT71 SNX6 EIF3A TAGLN2 ZW10 GCN1 HSPA4 | 2.60e-05 | 1314 | 110 | 20 | int:BAP1 |
| Interaction | TFCP2 interactions | TPM1 KRT6A KRT6B MYH9 HNRNPCL1 IMPDH2 SPTBN1 KRT76 MORF4L1 EIF3A HSPA4 | 2.67e-05 | 436 | 110 | 11 | int:TFCP2 |
| Interaction | EPS15 interactions | 2.80e-05 | 220 | 110 | 8 | int:EPS15 | |
| Interaction | ACE2 interactions | KRT1 KRT2 KRT5 KRT6B MYH9 IMPDH2 SPTBN1 FARSB LARP4 KRT80 EIF1AY KRT6C EIF3A TAGLN2 KIF5C OCLN GCN1 HSPA4 | 2.92e-05 | 1106 | 110 | 18 | int:ACE2 |
| Interaction | EFTUD2 interactions | ROCK2 KRT1 KRT2 KRT5 KRT6A KRT6B MYH9 ABCF1 IMPDH2 SPTBN1 FARSB LARP4 KRT6C EIF1AX MORF4L1 BYSL PGLS EIF3A TAGLN2 GCN1 HSPA4 | 3.27e-05 | 1449 | 110 | 21 | int:EFTUD2 |
| Interaction | CDK3 interactions | 3.81e-05 | 114 | 110 | 6 | int:CDK3 | |
| Interaction | PIK3R2 interactions | 3.84e-05 | 230 | 110 | 8 | int:PIK3R2 | |
| Interaction | TMEM260 interactions | 4.35e-05 | 13 | 110 | 3 | int:TMEM260 | |
| Interaction | NPHP4 interactions | 4.61e-05 | 236 | 110 | 8 | int:NPHP4 | |
| Interaction | MINDY4 interactions | 4.94e-05 | 73 | 110 | 5 | int:MINDY4 | |
| Interaction | INSIG2 interactions | 5.32e-05 | 177 | 110 | 7 | int:INSIG2 | |
| Interaction | DDX3X interactions | KRT1 KRT2 KRT4 KRT5 KRT6A KRT6B IMPDH2 LARP4 KRT80 KRT77 BYSL SECISBP2 EIF3A | 5.54e-05 | 651 | 110 | 13 | int:DDX3X |
| Interaction | FN1 interactions | KRT1 KRT2 KRT5 MYH9 ABCF1 IMPDH2 SPTBN1 FARSB ITIH4 KIDINS220 CLIC2 EIF3A TAGLN2 ZW10 GCN1 | 5.73e-05 | 848 | 110 | 15 | int:FN1 |
| Interaction | MECP2 interactions | KRT1 MTIF3 KRT2 KRT5 KRT6A MYH9 ABCF1 HNRNPCL1 IMPDH2 SPTBN1 DDX42 NEFM KIDINS220 EIF1AX GLYR1 MORF4L1 H1-6 NKAPL GCN1 | 6.43e-05 | 1287 | 110 | 19 | int:MECP2 |
| Interaction | NPHP3 interactions | 8.02e-05 | 42 | 110 | 4 | int:NPHP3 | |
| Interaction | PDE4DIP interactions | 8.05e-05 | 189 | 110 | 7 | int:PDE4DIP | |
| Interaction | CUL1 interactions | KRT1 KRT2 KRT5 MYH3 KRT6A KRT6B MYH9 HNRNPCL1 CAND2 SPTBN1 CCDC168 PPL KRT6C KIF5C HSPA4 | 8.25e-05 | 876 | 110 | 15 | int:CUL1 |
| Interaction | KRT71 interactions | 8.80e-05 | 43 | 110 | 4 | int:KRT71 | |
| Interaction | PHLPP1 interactions | 8.86e-05 | 333 | 110 | 9 | int:PHLPP1 | |
| Interaction | SYNPO interactions | 8.89e-05 | 192 | 110 | 7 | int:SYNPO | |
| Cytoband | 12q13.13 | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT80 KRT76 KRT6C KRT71 KRT77 | 1.04e-19 | 67 | 110 | 12 | 12q13.13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 LARP4 KRT80 KRT76 KRT6C KRT71 KRT77 ENDOU | 1.21e-13 | 423 | 110 | 15 | chr12q13 |
| Cytoband | 2p24 | 3.70e-04 | 12 | 110 | 2 | 2p24 | |
| GeneFamily | Keratins, type II | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 KRT80 KRT76 KRT6C KRT71 KRT77 | 4.70e-25 | 27 | 73 | 13 | 609 |
| GeneFamily | Myosin heavy chains | 1.71e-11 | 15 | 73 | 6 | 1098 | |
| GeneFamily | EF-hand domain containing|Plakins | 4.43e-04 | 8 | 73 | 2 | 939 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 4.43e-04 | 8 | 73 | 2 | 1122 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 1.03e-03 | 12 | 73 | 2 | 1290 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 3.21e-03 | 21 | 73 | 2 | 980 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 3.85e-03 | 23 | 73 | 2 | 1288 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 6.08e-03 | 29 | 73 | 2 | 754 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_LATE_SUPRABASAL_CELLS | 7.40e-09 | 140 | 109 | 9 | M40004 | |
| Coexpression | DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS | 1.25e-08 | 67 | 109 | 7 | M40299 | |
| Coexpression | GU_PDEF_TARGETS_DN | 6.64e-07 | 40 | 109 | 5 | M10480 | |
| Coexpression | DESCARTES_MAIN_FETAL_SQUAMOUS_EPITHELIAL_CELLS | 1.17e-06 | 129 | 109 | 7 | M40122 | |
| Coexpression | STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP | 1.51e-06 | 134 | 109 | 7 | MM748 | |
| Coexpression | DESCARTES_FETAL_EYE_SKELETAL_MUSCLE_CELLS | 7.29e-06 | 170 | 109 | 7 | M40176 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 8.18e-06 | 173 | 109 | 7 | M650 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING | KRT5 KRT6A KRT6B MYH9 ABCF1 CAPG SMC6 FARSB HMOX2 BBS9 EIF1AY EIF1AX MORF4L1 PGLS TAGLN2 HSPA4 | 1.10e-05 | 1088 | 109 | 16 | MM3699 |
| Coexpression | JAEGER_METASTASIS_DN | 1.35e-05 | 260 | 109 | 8 | M10702 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN | 1.68e-05 | 37 | 109 | 4 | MM570 | |
| Coexpression | WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN | 1.68e-05 | 37 | 109 | 4 | M16944 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP | 1.94e-05 | 13 | 109 | 3 | MM743 | |
| Coexpression | GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP | 2.09e-05 | 200 | 109 | 7 | M5185 | |
| Coexpression | HALLMARK_MYOGENESIS | 2.09e-05 | 200 | 109 | 7 | M5909 | |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN | 2.09e-05 | 200 | 109 | 7 | M8869 | |
| Coexpression | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 2.09e-05 | 200 | 109 | 7 | M78 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 2.38e-05 | 204 | 109 | 7 | MM966 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_39 | 2.38e-05 | 204 | 109 | 7 | MM17090 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 | 2.70e-05 | 84 | 109 | 5 | MM873 | |
| Coexpression | EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION | 4.78e-05 | 48 | 109 | 4 | M16123 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | KRT4 KRT5 KRT6A MYH9 CLIP2 DSG3 SPTBN1 KRT80 MORF4L1 TAGLN2 OCLN ZW10 ARHGAP21 | 4.88e-05 | 843 | 109 | 13 | M2356 |
| Coexpression | CROMER_TUMORIGENESIS_DN | 5.19e-05 | 49 | 109 | 4 | M16948 | |
| Coexpression | RICKMAN_HEAD_AND_NECK_CANCER_F | 8.20e-05 | 55 | 109 | 4 | M2043 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | CAND2 IMPDH2 HMOX2 MAGI2 FCHSD2 BYSL KCNMB1 ENDOU QSER1 HSPA4 | 1.44e-04 | 574 | 109 | 10 | M8215 |
| Coexpression | GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN | 1.64e-04 | 194 | 109 | 6 | M4687 | |
| Coexpression | DESCARTES_MAIN_FETAL_SKELETAL_MUSCLE_CELLS | 1.64e-04 | 194 | 109 | 6 | M40093 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | 1.73e-04 | 477 | 109 | 9 | M40930 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP | 1.83e-04 | 198 | 109 | 6 | M4295 | |
| Coexpression | AFFAR_YY1_TARGETS_UP | 1.88e-04 | 199 | 109 | 6 | M1466 | |
| Coexpression | KRAS.600.LUNG.BREAST_UP.V1_DN | 1.89e-04 | 284 | 109 | 7 | M2885 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN | 1.93e-04 | 200 | 109 | 6 | M7958 | |
| Coexpression | HALLMARK_KRAS_SIGNALING_DN | 1.93e-04 | 200 | 109 | 6 | M5956 | |
| Coexpression | BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE | 1.99e-04 | 69 | 109 | 4 | M2533 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | CAND2 IMPDH2 HMOX2 MAGI2 FCHSD2 BYSL KCNMB1 ENDOU QSER1 HSPA4 | 2.05e-04 | 600 | 109 | 10 | MM1025 |
| Coexpression | AFFAR_YY1_TARGETS_UP | 2.99e-04 | 217 | 109 | 6 | MM1156 | |
| CoexpressionAtlas | BM Top 100 - tongue superior part w_papillae | 2.70e-10 | 79 | 109 | 9 | BM Top 100 - tongue superior part w_papillae | |
| CoexpressionAtlas | BM Top 100 - oral mucosa | 4.24e-10 | 83 | 109 | 9 | BM Top 100 - oral mucosa | |
| CoexpressionAtlas | esophagus | KRT3 KRT4 KRT5 MYH3 KRT6A KRT6B DSG3 EVPL PPL KRT6C ENDOU SPINK5 | 5.43e-09 | 247 | 109 | 12 | esophagus |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | TPM1 ROCK2 MYH1 KRT4 MYH2 KRT5 MYH3 KRT6A MYH7 MYH9 MYOM1 NEB PPL NEFM ZNF106 ZFHX4 KIF5C OCLN SCN3B | 1.33e-08 | 772 | 109 | 19 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.64e-07 | 48 | 109 | 6 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k4 | |
| CoexpressionAtlas | BM Top 100 - tongue main corpus | 1.80e-07 | 80 | 109 | 7 | BM Top 100 - tongue main corpus | |
| CoexpressionAtlas | BM Top 100 - esophagus | 2.98e-07 | 86 | 109 | 7 | BM Top 100 - esophagus | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_100 | 7.29e-07 | 98 | 109 | 7 | PCBC_ctl_BronchioEpithel_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.82e-06 | 161 | 109 | 8 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k5 | |
| CoexpressionAtlas | BM Top 100 - pharyngeal mucosa | 5.01e-06 | 85 | 109 | 6 | BM Top 100 - pharyngeal mucosa | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | 5.09e-06 | 388 | 109 | 11 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_500 | 7.82e-06 | 406 | 109 | 11 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_1000 | KRT1 MYH1 KRT4 KRT5 MYH3 KRT6A MYH7 MYOM1 NEB ITIH4 NEFM OTC ZFHX4 KRT77 SCN3B | 1.55e-05 | 805 | 109 | 15 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.27e-05 | 311 | 109 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | BM Top 100 - vagina | 4.49e-05 | 76 | 109 | 5 | BM Top 100 - vagina | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 4.73e-05 | 407 | 109 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_500 | KRT4 KRT5 KRT6A KRT6B DSG3 UGT1A6 EVPL PPL KRT80 KRT6C SPINK5 | 4.94e-05 | 496 | 109 | 11 | PCBC_ctl_BronchioEpithel_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 6.06e-05 | 192 | 109 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | KRT4 KRT5 MYH3 KRT6A MYH7 MYH9 CAND2 CEP162 TNRC6C NEFM ZFHX4 SIPA1L1 KIF5C GCN1 | 6.53e-05 | 806 | 109 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.01e-04 | 90 | 109 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k4 | |
| CoexpressionAtlas | skin | 1.21e-04 | 456 | 109 | 10 | skin | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_100 | 1.51e-04 | 98 | 109 | 5 | PCBC_ctl_SmallAirwayEpithel_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_200 | 2.10e-04 | 165 | 109 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500_k-means-cluster#4 | 2.41e-04 | 59 | 109 | 4 | Arv_EB-LF_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.46e-04 | 24 | 109 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k5 | |
| CoexpressionAtlas | skeletal muscle | 2.48e-04 | 320 | 109 | 8 | skeletal muscle | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_500 | 2.79e-04 | 25 | 109 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | ABCF1 AFF2 SWT1 CEP162 SMC6 CNTLN KRT80 NEFM TTC8 KCNMB1 ENDOU PLCB2 EIF3A KIF5C QSER1 DMD HSPA4 SCN3B | 3.00e-04 | 1414 | 109 | 18 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_200 | 3.86e-04 | 6 | 109 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.89e-04 | 432 | 109 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_100 | 3.93e-04 | 28 | 109 | 3 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k1_100 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#5 | 4.34e-04 | 123 | 109 | 5 | Arv_EB-LF_1000_K5 | |
| CoexpressionAtlas | BM Top 100 - tonsil | 4.64e-04 | 70 | 109 | 4 | BM Top 100 - tonsil | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_500 | 5.33e-04 | 31 | 109 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_1000 | TPM1 GDF5 MYH1 MYH2 MYH3 MYH7 MYOM1 ZFHX4 EIF1AX KCNMB1 ENDOU SCN3B | 5.36e-04 | 761 | 109 | 12 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000 |
| CoexpressionAtlas | BM Top 100 - skeletal muscle | 6.03e-04 | 75 | 109 | 4 | BM Top 100 - skeletal muscle | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_1000 | TPM1 KRT4 MYH2 KRT5 KRT6A MYOM1 SPTBN1 PPL NEFM KCNMB1 EIF3A SCN3B | 6.23e-04 | 774 | 109 | 12 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_B |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#4_top-relative-expression-ranked_100 | 7.16e-04 | 8 | 109 | 2 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_500 | 8.26e-04 | 384 | 109 | 8 | gudmap_developingLowerUrinaryTract_P1_bladder_500_B | |
| CoexpressionAtlas | BM Top 100 - vulva | 8.45e-04 | 82 | 109 | 4 | BM Top 100 - vulva | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_500 | 8.83e-04 | 388 | 109 | 8 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_100 | 9.74e-04 | 38 | 109 | 3 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_100 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.37e-12 | 196 | 110 | 11 | 03de28e1c963e99623e8b0e33bf2e8ef67dc3baa | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.50e-12 | 197 | 110 | 11 | e621d4f9d4ba5e3ef17d2b477e5e14ea0251147e | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-6|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.63e-10 | 167 | 110 | 9 | 4a533972a0f40fff82dccf8e64716cb34f75736e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.14e-09 | 190 | 110 | 9 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.14e-09 | 190 | 110 | 9 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.14e-09 | 190 | 110 | 9 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.56e-09 | 197 | 110 | 9 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | Skin-Keratinocytes|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.78e-09 | 200 | 110 | 9 | 59d72395199bc30df0e811fbc99149694e208860 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.48e-09 | 163 | 110 | 8 | 6a12b802cb181f979ebc72674f3626fb855024e3 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-08 | 174 | 110 | 8 | 97d4a40b536a67fa52f055eab26106d041bf3220 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-08 | 174 | 110 | 8 | f9f399244c7d12caf8118ec3117d477a39e35c3b | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-08 | 174 | 110 | 8 | e8440eea7c81864defa57c89e9b569ad8033e5c5 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.36e-08 | 176 | 110 | 8 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-08 | 185 | 110 | 8 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.28e-08 | 197 | 110 | 8 | 9ee927d005eb17843e2516c8006eb192c6ad2af8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.41e-08 | 198 | 110 | 8 | 3371276410dba693c238b383d990b89371b14d8d | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.54e-08 | 199 | 110 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Kidney-Keratinocytes|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 3.68e-08 | 200 | 110 | 8 | 41d83faa9f45ee7ea2ab19be8ecc6d2c5ac7fe5d | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 2.41e-07 | 172 | 110 | 7 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.51e-07 | 173 | 110 | 7 | 1b2508cc890430bd4b2cf232c633928edb86c57e | |
| ToppCell | droplet-Tongue-nan-24m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-07 | 176 | 110 | 7 | 9739b0653c511ab017507a0c7ee4f6d7082e87db | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-07 | 178 | 110 | 7 | a3176b2b335db22bb0fb71aafa5d7a287809396e | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-07 | 181 | 110 | 7 | 6b43dcaeeb02ad5900772b6f16f1581847050e38 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-07 | 181 | 110 | 7 | f50561fdacfb83ba85fe6476e7cbc2bad1ebc826 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.95e-07 | 185 | 110 | 7 | f3fbc3096f85397a959cee17c3c4fcf2d511f3d5 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.25e-07 | 187 | 110 | 7 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-07 | 190 | 110 | 7 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.44e-07 | 194 | 110 | 7 | 614d0c25b56957c70f397abb169fd2a860eb1c06 | |
| ToppCell | droplet-Tongue|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-07 | 195 | 110 | 7 | e460b09ae354b579ce552acebdaa5877a6e62343 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.03e-07 | 197 | 110 | 7 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.03e-07 | 197 | 110 | 7 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.03e-07 | 197 | 110 | 7 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | distal-1-Epithelial-Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.03e-07 | 197 | 110 | 7 | 25a2ccc98b973611de0d920b1b455d0b40f0d37f | |
| ToppCell | distal-Epithelial-Basal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.03e-07 | 197 | 110 | 7 | 75b4292ce2ad7f9c8b6a4781e1cb71f5b18b74e3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.24e-07 | 198 | 110 | 7 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | Skin|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 6.45e-07 | 199 | 110 | 7 | 6be1340413ee868c610b6e3f58c65b493eb22bb5 | |
| ToppCell | distal-1-Epithelial-Proliferating_Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.45e-07 | 199 | 110 | 7 | 93450257180d918c310bca7b5defc74390c48091 | |
| ToppCell | distal-Epithelial-Proliferating_Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.67e-07 | 200 | 110 | 7 | 25cc494ef831511840d8c02ec1bd086635cc7edd | |
| ToppCell | distal-Epithelial-Proliferating_Basal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.67e-07 | 200 | 110 | 7 | cc31e8c28d01e6757c5dd7f485db6acf7409a47e | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.85e-06 | 168 | 110 | 6 | f150beee37e0252951a88adcd9e3f0a22e5cfdd9 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Squamous|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.71e-06 | 174 | 110 | 6 | 0a4721248ec89bc98ebe119de6e19fbfca8b5098 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.71e-06 | 174 | 110 | 6 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-06 | 175 | 110 | 6 | eb87275da6f61ecb4fbc89421dfd27bead1e0f48 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-06 | 175 | 110 | 6 | 3883675a726dd0c6c3a7113d59be2a093ea2dc6f | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-06 | 176 | 110 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.20e-06 | 177 | 110 | 6 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.54e-06 | 179 | 110 | 6 | 2b5f8e109a67c7fc3ec2b83e8f1854160c99283a | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-06 | 182 | 110 | 6 | 41f1749e2368397bca49143786da0423792f03bd | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.10e-06 | 182 | 110 | 6 | 007fa56ed8b91f9af0df2114c00410b2f6cec8b6 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-06 | 183 | 110 | 6 | 9e6c96ada930e8559246a270dfc69fb3cbb3bdf3 | |
| ToppCell | droplet-Skin|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-06 | 185 | 110 | 6 | 657fd191ed160f8620d57b33820ec7222806f289 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-06 | 186 | 110 | 6 | 9a7932d0a208f3997216bd21a72913cc82b59fc9 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-06 | 188 | 110 | 6 | ed35e438796cef302b6787c111753425922792dc | |
| ToppCell | Club-club-5|World / Class top | 7.34e-06 | 188 | 110 | 6 | 5911409108ececdb4f8112ec4bacc215e204001f | |
| ToppCell | SupraBC-Differ-KC|World / shred by cell class for mouse tongue | 7.57e-06 | 189 | 110 | 6 | 6412741b88e241304033b41effca0c77a374d907 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 7.57e-06 | 189 | 110 | 6 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.80e-06 | 190 | 110 | 6 | 719a5cecc3e8001ca9c38165258b5ff9c800713a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.03e-06 | 191 | 110 | 6 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-06 | 191 | 110 | 6 | c5ef34d138cd797029dfefaf4c52d16ba6a76c38 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-06 | 193 | 110 | 6 | 33437fdb417d78463caee14a9f0e094da1733829 | |
| ToppCell | facs-Tongue|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-06 | 195 | 110 | 6 | 77128895db9221a64a171082d468ebcd6380c936 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.58e-06 | 197 | 110 | 6 | 751f19b00f92e1334f653b870d3f7c0c149ff41a | |
| ToppCell | NS-control-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.58e-06 | 197 | 110 | 6 | ab965a0ba87efd3329d24a1ec123985f46fc17c0 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.58e-06 | 197 | 110 | 6 | 2701864e49878c5f323f5133e2c4b0a5a7fff7f5 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.58e-06 | 197 | 110 | 6 | de772bd2b4cda843777ac879b1087e6444199dfb | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.58e-06 | 197 | 110 | 6 | 58d809ccb8cc4b1e76acf0b8f996cd0e2637290c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.86e-06 | 198 | 110 | 6 | 89ec1e760a193441092571475cc66a3b425f232e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.86e-06 | 198 | 110 | 6 | fb3965049cb1961de0d2e74370868e46aa5050c8 | |
| ToppCell | (5)_Epithelial_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 9.86e-06 | 198 | 110 | 6 | 6dd7dd356d55c03bb14fa47cc69764403c3f48d4 | |
| ToppCell | COVID-19-Heart-Mito_CM|Heart / Disease (COVID-19 only), tissue and cell type | 9.86e-06 | 198 | 110 | 6 | b6cd439863d17209b86dc50ae51282dc1725955d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.86e-06 | 198 | 110 | 6 | 72d91bd0c727ecadc41e023a16c9326158db1b7b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.86e-06 | 198 | 110 | 6 | 96236fa22545f6f4ff3aa8dc002963db8a3468ce | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 9.86e-06 | 198 | 110 | 6 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 9.86e-06 | 198 | 110 | 6 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.86e-06 | 198 | 110 | 6 | 441608034c787e55691558a480dcd07e37419138 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.86e-06 | 198 | 110 | 6 | 9f5726aedd1fb132feab717a029fa302306461b5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.86e-06 | 198 | 110 | 6 | 9e0fdd63069d17430cdc25bf4ffc762afd5e1728 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.86e-06 | 198 | 110 | 6 | 7eb521af938c2609a85d27e2aa7d4317ad6e1e44 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 1.01e-05 | 199 | 110 | 6 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.04e-05 | 200 | 110 | 6 | c7668e26c6b8cfa6d174b0634e43c230425faba9 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 110 | 6 | afac850d5a40de0d6f02857cf81a19443d90b1eb | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.04e-05 | 200 | 110 | 6 | bce9bce9eb622bc6514708d49ca4a6604043c22a | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 110 | 6 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.04e-05 | 200 | 110 | 6 | 7595eb2a8af3de879ecaa71f3d96f890e13b59ce | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-05 | 200 | 110 | 6 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.04e-05 | 200 | 110 | 6 | 621dd6438ef6e71811d3644b75209535b7c0f8f7 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 110 | 6 | 9da214f756a03516eaafde00289b90f69623b9f3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-05 | 200 | 110 | 6 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Basal_2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.04e-05 | 200 | 110 | 6 | 0fa3340d945f00ef55c7603476d51bd8346e82c2 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 110 | 6 | ce969c958a31145bbfe315a9a865d7900ecc9549 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 110 | 6 | 0594ca7bc313b73e1dc800cf058f8f798b0284cb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 200 | 110 | 6 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.93e-05 | 144 | 110 | 5 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-05 | 153 | 110 | 5 | 3b1b0cc8e9dd2b1484649789330713282ee44414 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.99e-05 | 77 | 110 | 4 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.42e-05 | 157 | 110 | 5 | 2553ebf3e48de5bd184e77bd61114faa5a1d95ed | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 158 | 110 | 5 | bd37d567754b660bfff7aef81cb307a384ec20a0 | |
| ToppCell | LPS-IL1RA-Epithelial_airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.98e-05 | 161 | 110 | 5 | 472c354f5ee148b37a5dfb795e83348ecb1643f1 | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 5.29e-05 | 163 | 110 | 5 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 5.44e-05 | 164 | 110 | 5 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| Computational | Intermediate filaments and MT. | 5.83e-10 | 68 | 72 | 9 | MODULE_438 | |
| Computational | Genes in the cancer module 68. | 1.51e-08 | 26 | 72 | 6 | MODULE_68 | |
| Computational | Keratin. | 1.51e-08 | 26 | 72 | 6 | MODULE_298 | |
| Computational | Genes in the cancer module 201. | 9.20e-07 | 50 | 72 | 6 | MODULE_201 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.20e-07 | 50 | 72 | 6 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN | |
| Computational | Genes in the cancer module 153. | 2.80e-06 | 34 | 72 | 5 | MODULE_153 | |
| Computational | Neighborhood of SPRR1B | 1.78e-05 | 24 | 72 | 4 | GNF2_SPRR1B | |
| Computational | Genes in the cancer module 202. | 3.36e-05 | 28 | 72 | 4 | MODULE_202 | |
| Computational | Muscle genes. | 1.03e-04 | 37 | 72 | 4 | MODULE_512 | |
| Computational | Genes in the cancer module 387. | 3.12e-04 | 49 | 72 | 4 | MODULE_387 | |
| Computational | Genes in the cancer module 329. | 3.65e-04 | 51 | 72 | 4 | MODULE_329 | |
| Computational | Neighborhood of TTN | 6.71e-04 | 26 | 72 | 3 | GNF2_TTN | |
| Computational | Genes in the cancer module 419. | 1.49e-03 | 34 | 72 | 3 | MODULE_419 | |
| Computational | Neighborhood of CTSB | 1.54e-03 | 187 | 72 | 6 | MORF_CTSB | |
| Computational | Neighborhood of IL4 | 1.77e-03 | 192 | 72 | 6 | MORF_IL4 | |
| Computational | Neighborhood of MAGEA9 | 1.96e-03 | 423 | 72 | 9 | MORF_MAGEA9 | |
| Computational | Neighborhood of PAX7 | 1.96e-03 | 266 | 72 | 7 | MORF_PAX7 | |
| Computational | Intermediate filaments and keratins. | 1.99e-03 | 80 | 72 | 4 | MODULE_357 | |
| Computational | Genes in the cancer module 297. | 1.99e-03 | 80 | 72 | 4 | MODULE_297 | |
| Drug | homocysteine thiolactone | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B IMPDH2 KRT84 KRT76 KRT6C KRT71 KRT77 | 6.04e-14 | 131 | 109 | 13 | CID000107712 |
| Drug | teleocidin B | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 KRT76 KRT6C KRT71 KRT77 | 7.20e-13 | 123 | 109 | 12 | CID000072425 |
| Drug | al-Badry | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 UGT1A6 KRT76 KRT6C KRT71 KRT77 | 1.21e-12 | 165 | 109 | 13 | CID000004545 |
| Drug | sulfur mustard | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 KRT76 KRT6C KRT71 KRT77 | 1.40e-12 | 130 | 109 | 12 | CID000010461 |
| Drug | AC1L9MJT | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B CLIP2 KRT84 EVPL PPL KRT6C KRT77 | 8.36e-12 | 192 | 109 | 13 | CID000448959 |
| Drug | B0683 | 1.03e-11 | 117 | 109 | 11 | CID006398969 | |
| Drug | NSC339663 | ROCK2 MYH1 MYH2 MYH3 KRT6A KRT6B MYH7 MYH9 MYH13 EVPL PPL KRT6C EIF3A | 2.27e-10 | 250 | 109 | 13 | CID000003892 |
| Drug | 1-2q | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 TTC8 KRT6C KRT77 SPINK5 DNTT | 1.34e-09 | 289 | 109 | 13 | CID000011820 |
| Drug | Velcade (bortezomib | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B KRT84 KRT76 KRT6C KRT71 KRT77 H1-6 HSPA4 | 3.20e-09 | 374 | 109 | 14 | CID000093860 |
| Drug | plakin | 5.65e-09 | 82 | 109 | 8 | CID000018752 | |
| Drug | SC-791 | 7.40e-09 | 6 | 109 | 4 | CID010291510 | |
| Drug | bilirubin-phosphate | 9.60e-09 | 16 | 109 | 5 | CID005497144 | |
| Drug | purealin | 1.17e-08 | 58 | 109 | 7 | CID006419303 | |
| Drug | AC1NRBPQ | 2.03e-08 | 137 | 109 | 9 | CID005288569 | |
| Drug | fast white | 4.78e-08 | 42 | 109 | 6 | CID000024008 | |
| Drug | oxovanadium | 1.15e-07 | 120 | 109 | 8 | CID000024411 | |
| Drug | MgCl2 | TPM1 KRT1 MYH1 MYH2 MYH3 MYH7 MYH9 MYH13 CAPG SPTBN1 NEFM H1-6 | 1.34e-07 | 354 | 109 | 12 | CID000024584 |
| Drug | formycin triphosphate | 1.58e-07 | 51 | 109 | 6 | CID000122274 | |
| Drug | eye gene | ROCK2 MYH1 MYH2 MYH3 KRT6A KRT6B MYH7 MYH9 MYH13 KRT6C PLCB2 HSPA4 | 2.10e-07 | 369 | 109 | 12 | CID000004782 |
| Drug | clenbuterol | 4.20e-07 | 142 | 109 | 8 | CID000002783 | |
| Drug | ethylnylestradiol | KRT1 KRT2 KRT3 MYH1 KRT4 KRT5 KRT6A KRT6B MYH13 CLIP2 KRT84 UGT1A6 HMOX2 BBS9 BRD8 KRT76 KRT6C KRT71 KRT77 NR5A1 HSPA4 | 4.31e-07 | 1251 | 109 | 21 | CID000003285 |
| Drug | nocodazole | ROCK2 MYH1 MYH2 MYH3 MYH7 MYH9 MYH13 EVPL VPS54 EIF1AX EIF3A ZW10 HSPA4 | 4.78e-07 | 477 | 109 | 13 | CID000004122 |
| Drug | phorbol acetate myristate | ROCK2 KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B LILRB3 MYH9 IMPDH2 KRT84 HMOX2 KRT76 KIDINS220 KRT6C KRT71 KRT77 H1-6 PLCB2 HSPA4 DNTT | 6.60e-07 | 1399 | 109 | 22 | CID000004792 |
| Drug | butyrate | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B AFF2 KRT84 OTC KRT76 KRT6C KRT71 KRT77 H1-6 HSPA4 | 7.57e-07 | 767 | 109 | 16 | CID000000264 |
| Drug | adenosine 3',5'-cyclic phosphate | KRT1 KRT2 KRT3 KRT4 KRT5 KRT6A KRT6B LILRB3 KRT84 KRT76 KRT6C KRT71 CLIC2 KRT77 PLCB2 DMD DNTT | 1.44e-06 | 907 | 109 | 17 | CID000000274 |
| Drug | blebbistatin | 1.44e-06 | 116 | 109 | 7 | CID003476986 | |
| Drug | dithranol | 1.44e-06 | 18 | 109 | 4 | CID000002202 | |
| Drug | phenyl isocyanate | 2.11e-06 | 6 | 109 | 3 | ctd:C025319 | |
| Drug | AC1LADJ6 | 3.09e-06 | 130 | 109 | 7 | CID000486032 | |
| Drug | MK-6 | 4.91e-06 | 24 | 109 | 4 | CID005283547 | |
| Drug | Ramipril [87333-19-5]; Up 200; 9.6uM; HL60; HT_HG-U133A | 5.48e-06 | 200 | 109 | 8 | 6150_UP | |
| Drug | 4-chloroaniline | 5.90e-06 | 202 | 109 | 8 | CID000007812 | |
| Drug | DIMIT | 7.21e-06 | 56 | 109 | 5 | CID000006624 | |
| Drug | S-(-)-Etomoxir | 8.67e-06 | 100 | 109 | 6 | CID000060765 | |
| Drug | Dietary Sucrose | KRT2 FAM184B MYH3 MYH7 DSG3 KRT84 UGT1A6 GRIN1 NEB NEFM KRT76 SNX32 KRT77 NR5A1 SCN3B SPINK5 | 1.05e-05 | 942 | 109 | 16 | ctd:D019422 |
| Drug | 2-Formyl-Protoporphryn Ix | 1.42e-05 | 31 | 109 | 4 | CID011963946 | |
| Drug | NSC107658 | 1.67e-05 | 306 | 109 | 9 | CID000002919 | |
| Drug | benzyl nicotinate | 2.27e-05 | 2 | 109 | 2 | CID000007191 | |
| Drug | isobutoxy | 2.27e-05 | 2 | 109 | 2 | CID000010557 | |
| Drug | chrysarobin | 2.91e-05 | 37 | 109 | 4 | CID000068111 | |
| Drug | N-nitrosomorpholine | 3.65e-05 | 338 | 109 | 9 | ctd:C002741 | |
| Drug | diacetylene | 3.74e-05 | 14 | 109 | 3 | CID000009997 | |
| Drug | creatine | 4.05e-05 | 193 | 109 | 7 | CID000000586 | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Down 200; 15.8uM; PC3; HT_HG-U133A | 4.33e-05 | 195 | 109 | 7 | 6698_DN | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A | 4.47e-05 | 196 | 109 | 7 | 5240_DN | |
| Drug | Proguanil hydrochloride [637-32-1]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 4.62e-05 | 197 | 109 | 7 | 5506_UP | |
| Drug | 3-deoxy-3-fluoro-D-glucose | 4.66e-05 | 15 | 109 | 3 | CID000450201 | |
| Drug | iodine fluoride | 4.66e-05 | 15 | 109 | 3 | CID000522683 | |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; PC3; HT_HG-U133A | 4.92e-05 | 199 | 109 | 7 | 5788_DN | |
| Drug | Zinc Sulfate | MYH7 SPTBN1 BBS9 KRT80 NEFM MAGI2 SIDT2 BRD8 TMEM232 SIPA1L1 KIF5C OCLN HSPA4 | 5.32e-05 | 739 | 109 | 13 | ctd:D019287 |
| Drug | SM-2 | 6.20e-05 | 87 | 109 | 5 | CID000486033 | |
| Drug | tryptophan ethyl ester | 6.79e-05 | 3 | 109 | 2 | CID000081996 | |
| Drug | clobestasol propionate | 6.91e-05 | 17 | 109 | 3 | CID000002791 | |
| Drug | K-11 | 6.91e-05 | 17 | 109 | 3 | CID000469667 | |
| Drug | candesartan cilexetil | 7.11e-05 | 145 | 109 | 6 | CID000002540 | |
| Drug | sodium dodecyl sulfate | 7.69e-05 | 91 | 109 | 5 | CID000008778 | |
| Drug | phenazine ethosulfate | 9.78e-05 | 19 | 109 | 3 | CID000082688 | |
| Drug | Olux | 1.15e-04 | 20 | 109 | 3 | CID000032797 | |
| Drug | AC1NPJ0T | 1.15e-04 | 20 | 109 | 3 | CID005159168 | |
| Drug | N1-acetylspermidine | 1.15e-04 | 20 | 109 | 3 | CID000000496 | |
| Drug | carvedilol | 1.27e-04 | 161 | 109 | 6 | CID000002585 | |
| Drug | PE-3 | 1.33e-04 | 21 | 109 | 3 | CID000025056 | |
| Drug | verdohemochrome | 1.35e-04 | 4 | 109 | 2 | CID006443303 | |
| Drug | cignolin | 1.51e-04 | 56 | 109 | 4 | CID000010187 | |
| Drug | 2-morpholinoethyl isocyanide | 1.61e-04 | 57 | 109 | 4 | CID002759434 | |
| Drug | trifluoperazine | 1.69e-04 | 324 | 109 | 8 | CID000005566 | |
| Drug | CK 6 | 1.73e-04 | 58 | 109 | 4 | CID000447960 | |
| Drug | AC1NSKHI | 2.10e-04 | 61 | 109 | 4 | CID005311358 | |
| Drug | 3-Nitrobenzaldoxime | 2.22e-04 | 114 | 109 | 5 | CID000219132 | |
| Drug | Bhg-(2-1)fuc | 2.27e-04 | 25 | 109 | 3 | CID005287784 | |
| Drug | AC1NQAMW | 2.27e-04 | 25 | 109 | 3 | CID005193001 | |
| Drug | Spermine | 2.38e-04 | 63 | 109 | 4 | ctd:D013096 | |
| Drug | LY294002 | ROCK2 MYH1 MYH2 MYH3 MYH7 MYH9 MYH13 CEP162 HMOX2 FES HSPA4 DNTT | 2.46e-04 | 748 | 109 | 12 | CID000003973 |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.23e-10 | 10 | 104 | 5 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.23e-10 | 10 | 104 | 5 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.23e-10 | 10 | 104 | 5 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.23e-10 | 10 | 104 | 5 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.23e-10 | 10 | 104 | 5 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.23e-10 | 10 | 104 | 5 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.23e-10 | 10 | 104 | 5 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.23e-10 | 10 | 104 | 5 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 3.83e-10 | 12 | 104 | 5 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 3.83e-10 | 12 | 104 | 5 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 6.21e-10 | 13 | 104 | 5 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.44e-09 | 15 | 104 | 5 | DOID:0050646 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.42e-08 | 80 | 104 | 7 | DOID:12930 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 7.49e-07 | 48 | 104 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 5.34e-06 | 71 | 104 | 5 | DOID:0050700 (implicated_via_orthology) | |
| Disease | uveal melanoma (implicated_via_orthology) | 1.23e-05 | 2 | 104 | 2 | DOID:6039 (implicated_via_orthology) | |
| Disease | cinnamaldehyde measurement | 1.23e-05 | 2 | 104 | 2 | EFO_0021839 | |
| Disease | age at onset, Parkinson disease | 3.34e-05 | 18 | 104 | 3 | EFO_0004847, MONDO_0005180 | |
| Disease | sphingomyelin measurement | 5.96e-05 | 278 | 104 | 7 | EFO_0010118 | |
| Disease | Pachyonychia congenita syndrome | 7.35e-05 | 4 | 104 | 2 | cv:C0265334 | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 7.35e-05 | 4 | 104 | 2 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 7.35e-05 | 4 | 104 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 7.35e-05 | 4 | 104 | 2 | C1721007 | |
| Disease | Pachyonychia Congenita | 1.22e-04 | 5 | 104 | 2 | C0265334 | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 2.55e-04 | 7 | 104 | 2 | C0700053 | |
| Disease | Obstructive asymmetric septal hypertrophy | 2.55e-04 | 7 | 104 | 2 | C0597124 | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 4.36e-04 | 9 | 104 | 2 | C0949658 | |
| Disease | Familial dilated cardiomyopathy | 5.07e-04 | 44 | 104 | 3 | C0340427 | |
| Disease | anterior thigh muscle volume | 5.44e-04 | 10 | 104 | 2 | EFO_0020935 | |
| Disease | Bardet-Biedl syndrome (implicated_via_orthology) | 6.63e-04 | 11 | 104 | 2 | DOID:1935 (implicated_via_orthology) | |
| Disease | motor neuron disease (implicated_via_orthology) | 7.94e-04 | 12 | 104 | 2 | DOID:231 (implicated_via_orthology) | |
| Disease | Polydactyly | 7.95e-04 | 117 | 104 | 4 | C0152427 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 9.36e-04 | 13 | 104 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 9.36e-04 | 13 | 104 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 9.36e-04 | 13 | 104 | 2 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 9.36e-04 | 13 | 104 | 2 | C4551952 | |
| Disease | Congenital Structural Myopathy | 9.36e-04 | 13 | 104 | 2 | C0752282 | |
| Disease | Hypertrophic Cardiomyopathy | 1.08e-03 | 57 | 104 | 3 | C0007194 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 1.09e-03 | 14 | 104 | 2 | C1834558 | |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 1.09e-03 | 14 | 104 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | Tubular Aggregate Myopathy | 1.09e-03 | 14 | 104 | 2 | C0410207 | |
| Disease | colonic neoplasm, overall survival | 1.09e-03 | 14 | 104 | 2 | EFO_0000638, EFO_0004288 | |
| Disease | Left ventricular noncompaction | 1.09e-03 | 14 | 104 | 2 | C1960469 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 1.25e-03 | 15 | 104 | 2 | C3645536 | |
| Disease | Keratoderma, Palmoplantar | 1.43e-03 | 16 | 104 | 2 | C4551675 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 1.62e-03 | 17 | 104 | 2 | C2936862 | |
| Disease | Congenital Fiber Type Disproportion | 1.81e-03 | 18 | 104 | 2 | C0546264 | |
| Disease | Bardet-Biedl syndrome | 1.81e-03 | 18 | 104 | 2 | cv:C0752166 | |
| Disease | Contact Dermatitis | 2.04e-03 | 71 | 104 | 3 | C0011616 | |
| Disease | Contact hypersensitivity | 2.04e-03 | 71 | 104 | 3 | C0162351 | |
| Disease | base metabolic rate measurement | 2.24e-03 | 20 | 104 | 2 | EFO_0007777 | |
| Disease | Primary familial hypertrophic cardiomyopathy | 2.71e-03 | 22 | 104 | 2 | cv:C0949658 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EYERQVASLKAANAA | 266 | Q8NE71 | |
| EARKEVEVSQSKYNA | 291 | Q9NXG0 | |
| EAAEDYAKKLRQAFQ | 121 | O95336 | |
| AEVKRKATDAAYQAR | 156 | Q9H0E9 | |
| KATDAAYQARQAVKT | 161 | Q9H0E9 | |
| KVAEYTNKGDALANR | 56 | P51816 | |
| RAESQQDAASLKKAY | 11 | Q8IYW2 | |
| AEVDKLRAANEKYAQ | 576 | Q9UDT6 | |
| KQLAAYIADKVDAAQ | 1391 | P11532 | |
| KEKAEAQAQYSAAVA | 96 | Q14624 | |
| NAQESTYKVSKADDR | 591 | Q2KHR3 | |
| AAADEYNRLKQVKGS | 476 | Q16625 | |
| KAYKRQAEEAEEQAN | 1876 | P12883 | |
| DNYQTARADVEKVRA | 111 | Q16558 | |
| KKYEDEINKRTAAEN | 271 | Q01546 | |
| KSRGNTDNKEYAVNE | 241 | Q9UBU8 | |
| AIDEDTNKAASNVKY | 411 | P32926 | |
| QYDKEKNARAAVAGE | 56 | O60812 | |
| KYADIDIRGQDNKTA | 291 | Q9ULH0 | |
| NKYEDEINKRTAAEN | 251 | P48668 | |
| KKYEEEVVCRANAEN | 251 | Q9NSB2 | |
| EDINNKKIRYSAVFE | 1781 | Q86XX4 | |
| NEIKARSGQDDKTVY | 356 | P43026 | |
| ENSYRSEVKARQDVK | 1066 | Q86UL8 | |
| QYDKEKNARAAVAGE | 56 | B2RXH8 | |
| EKERNDAKNAVEEYV | 611 | P34932 | |
| NKYEDEINKRTAAEN | 251 | P02538 | |
| NVTSSEKVDKAQRYA | 226 | Q8NCE2 | |
| YFQAENEEKKKAEAR | 336 | Q9NQ38 | |
| QYDKEKNARAAVAGE | 56 | B7ZW38 | |
| SQNRYFSEADKIKVA | 426 | P12268 | |
| KKYEDEINKRTAAEN | 266 | P35908 | |
| AQYEDIAQRSKAEAE | 376 | P12035 | |
| NKYEDEINKRTTAEN | 256 | P13647 | |
| ENQQLSKDYARKAEE | 206 | Q9ULE4 | |
| KYEEEINKRTAAEND | 226 | P19013 | |
| KAQYDAVAARSLEEA | 256 | Q6KB66 | |
| KSAYADDNQITVVEK | 2221 | Q5CZC0 | |
| KIGSKRANFDEENAY | 61 | Q86XP3 | |
| RAFSKNEEKAYKETQ | 241 | Q9H2K0 | |
| NEEKAYKETQETQER | 246 | Q9H2K0 | |
| AQYEDIAQKSKAEAE | 356 | P04264 | |
| NKYEDEINKRTAAEN | 251 | P04259 | |
| DASVTKLAEQYAKEN | 226 | P00480 | |
| VKSYKRQAEEAEEQS | 1881 | Q9UKX2 | |
| QYEDEAAKARASQRE | 1136 | O60437 | |
| EKIYRADTNKAQKED | 146 | P21128 | |
| QEKNLAKAYTEVAAA | 856 | Q92817 | |
| AANEVYKRAKALDQS | 526 | Q49A26 | |
| DNKADVILKYNADEA | 86 | O14602 | |
| QYDKEKNARAAVAGE | 56 | P0DMR1 | |
| TKDKNTVVRAYSDQA | 2601 | Q92616 | |
| ENLYAAVKDTQSEDR | 511 | O75022 | |
| QAKVKSYKRQAEEAE | 1876 | P12882 | |
| SYKRQAEEAEEQSNV | 1881 | P12882 | |
| RNAEQYKDQADKAST | 1856 | P35579 | |
| KERIVEEANKAFEYN | 216 | P30519 | |
| KNARAEQKCAEALYT | 176 | Q9H4K1 | |
| KYQVLAFATDADKRQ | 206 | Q3SYG4 | |
| AAAGYDVEKNNSRIK | 71 | P22492 | |
| AARQSVYEEKLKQFE | 766 | Q14152 | |
| RDQAKDQIAYVTGEK | 826 | Q5TB80 | |
| TDAQQAFKYLREEVK | 246 | Q71RC2 | |
| KDNIREAFQIYDKEA | 576 | Q5JVL4 | |
| ADKANAQAAALYKVS | 241 | P40121 | |
| ATDDAISNKYDKQNI | 2601 | Q8NDH2 | |
| TFSQKKAAIEREYAQ | 41 | O94868 | |
| KEREENVKADVFTAY | 386 | O75155 | |
| VQRYKADLATDQKEA | 386 | Q13895 | |
| QEKDKAYVQARVLES | 91 | A0A087WTH5 | |
| EDKEIENTYANVAKQ | 231 | O15247 | |
| ARDSAQAKRKYQEAS | 146 | P07332 | |
| YVQVNKEAADDKSVA | 206 | Q5T160 | |
| KNNRDSAVASEYELV | 686 | O15211 | |
| AREVADSYAQNAKVI | 171 | Q9H5V9 | |
| KDAQEKANAALLDYT | 391 | Q13285 | |
| NAVVRYSSKEEAAKA | 1551 | Q9HCJ0 | |
| KNVSQKDAEFERTYV | 26 | Q8NBJ9 | |
| SREVQQKIEKQYDAD | 11 | P37802 | |
| EVKAVLNDERYQSFK | 236 | P04053 | |
| VNYDQKSQEVEDKTR | 496 | O60282 | |
| NLVDAAKAYEVQRAS | 1681 | O43166 | |
| KKTYDQQKFDSERAD | 151 | Q96T21 | |
| VKSYKRQAEEADEQA | 1876 | P11055 | |
| DSNNSKTKQEEREYL | 256 | Q5T5J6 | |
| VIKDSNTDVGAKNYR | 481 | Q9NSD9 | |
| QAAYAGDKADDIQKR | 1871 | Q01082 | |
| KENQIYSADEKRALA | 356 | Q5M9Q1 | |
| ARKSYENQAETKDNE | 2236 | Q86UP3 | |
| DLQRSYVAAQKSEAA | 506 | Q8TAM2 | |
| QKTKDYEEDVRIQNA | 466 | C9JQI7 | |
| YKVQQKDVSDEDVAR | 491 | Q9H269 | |
| QENYDKVKSERDALE | 261 | Q8WXW3 | |
| QAKVKSYKRQAEEAE | 1876 | Q9UKX3 | |
| SYKRQAEEAEEQANT | 1881 | Q9UKX3 | |
| KNAEYQRKADHEADK | 511 | O75116 | |
| YRKVSKAEEAAQENA | 181 | Q9NY72 | |
| ADVVAKKRAYNEAEV | 351 | Q96SB8 | |
| EKQFQKEALAEYEAR | 1116 | Q00722 | |
| SLVDYENANKALDKA | 316 | Q9UNH7 | |
| GTQVKEDRADYKEFQ | 11 | Q3C1V9 | |
| SLEAQAEKYSQKEDR | 206 | P09493 | |
| YENKGKIAQATDRSD | 341 | Q8N806 | |
| KRKDLSQEFEAYINA | 281 | P19224 | |
| DYENANKALDKARTR | 316 | Q86XE0 | |
| TNDKYADFIEANRKE | 1236 | Q5T5U3 | |
| NYAKASRNVEESEKG | 561 | Q9H2Y7 | |
| KNAAKDNSLDTEVAY | 496 | Q9P1Q0 | |
| EENYSAASKAVRQVL | 616 | O43264 | |
| DNKADVILKYNADEA | 86 | P47813 | |
| AQRSKDEAEALYQTK | 346 | Q7Z794 | |
| VDAAYANKVELQAKV | 241 | Q3SY84 | |
| ANVKAVSEEAYKISN | 986 | P52179 | |
| AKAARQAASDVQYKK | 1076 | P20929 | |
| DVIQARKAYDLQSDA | 3611 | P20929 | |
| AAKLSSQVKYRENFD | 5786 | P20929 | |
| KDANNLASEVKYKAD | 5821 | P20929 | |
| YESAAEAIQAVRDNK | 711 | Q05586 | |
| YAKLTEAAEQNKEAI | 296 | P07197 |